Malignant neoplasm of digestive organs

C3_DIGESTIVE_ORGANS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints C3_OESOPHAGUS C3_STOMACH C3_SMALL_INTESTINE C3_COLON C3_RECTOSIGMOID_JUNCTION C3_RECTUM C3_ANUS_ANALCANAL C3_BILIARY_GALLBLADDER C3_PANCREAS C3_DIGESTIVE_ORGANS_NAS	19525
6. Filter based on genotype QC (FinnGen only)	18914

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF9

NAME	C3_DIGESTIVE_ORGANS
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	C3_OESOPHAGUS\|C3_STOMACH\|C3_SMALL_INTESTINE\|C3_COLON\|C3_RECTOSIGMOID_JUNCTION\|C3_RECTUM\|C3_ANUS_ANALCANAL\|C3_BILIARY_GALLBLADDER\|C3_PANCREAS\|C3_DIGESTIVE_ORGANS_NAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of digestive organs based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	18914	7530	11384
Unadjusted period prevalence (%)	4.20	2.67	5.22
Median age at first event (years)	69.51	68.45	70.21

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
19256: Matched controls
151963

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

NK6AN

NOMESCO Finland

Total body bone isotope imaging

22.8

320.5

276

107

Kela drug reimbursment

Pernicious anaemia

4.9

317.0

776

1287

369

Kela drug reimbursment

Regorafenib

+∞

314.3

330

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

311.4

327

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

51.2

311.0

218

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

5.8

309.9

629

874

D64.9

ICD-10 Finland

Anaemia, unspecified

2.3

309.2

2722

10003

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

308.5

324

R50.9

ICD-10 Finland

Fever, unspecified

2.4

307.7

3060

11038

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

307.7

5163

19756

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

307.7

600

JAH01

NOMESCO Finland

Laparoscopy

6.2

307.7

1333

1789

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

1616.5

307.7

619

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

307.7

439

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

49.1

307.7

252

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

6.7

307.7

4019

5770

L02BG04

ATC

letrozole; oral

25.4

307.7

425

135

L03AA13

ATC

pegfilgrastim; parenteral

885.1

307.7

858

A04AA01

ATC

ondansetron; systemic, rectal

16.5

307.7

2935

1642

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.5

307.7

2443

6090

B01AB10

ATC

tinzaparin; parenteral

4.9

307.7

2970

5406

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

7.1

307.7

1121

1308

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

307.7

868

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

37.4

307.7

358

JG1CG

NOMESCO Finland

Extensive MRI of rectum

116.3

307.7

600

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

2827.7

307.7

707

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

3.0

307.7

1756

4846

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

307.7

487

UJF32

NOMESCO Finland

Coloscopy

4.5

307.7

9270

25906

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

2147.3

307.7

545

TPX10

NOMESCO Finland

Implantation of vascular injection port

12.8

307.7

1572

1049

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

7144.8

307.7

873

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

3779.9

307.7

929

WW500

NOMESCO Finland

Blood transfusion

9.2

307.7

1354

1237

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

307.7

1202

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.1

307.7

3093

8881

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

307.7

9262

51377

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

25.9

307.7

693

219

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

307.7

1973

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

+∞

307.7

666

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

73.3

307.7

409

D70.82

ICD-10 Finland

Drug-induced neutropenia

20.4

307.7

358

141

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

5552.9

307.7

687

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

41.3

307.7

314

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

5.5

307.7

1107

1672

B01AB05

ATC

enoxaparin; parenteral

3.8

307.7

9216

29417

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

307.7

696

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

+∞

307.7

369

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

307.7

474

176

Kela drug reimbursment

Regorafenib

+∞

307.7

340

JLC30

NOMESCO Finland

Pancreatoduodenectomy

95.4

307.7

586

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

12.6

307.7

837

546

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

5943.6

307.7

733

JCF12

NOMESCO Finland

Endoscopic insertion of prosthetic tube into oesphagus

73.8

307.7

519

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

7.1

307.7

864

997

JN3AD

NOMESCO Finland

Abdominal CT examination

3.9

307.7

3496

8227

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

11400.6

307.7

2531

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

6.0

307.7

2526

3726

WF003

NOMESCO Finland

Adjuvant radiotherapy

191.7

307.7

497

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

145.7

307.7

237

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

16384.0

307.7

2289

D77

ICPC

Malignant digestive neopl other/NOS

338.0

307.7

419

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

3323.0

307.7

420

A03FA01

ATC

metoclopramide; systemic, rectal

15.0

307.7

9710

9622

WX600

NOMESCO Finland

Single shot through catheter

27.6

307.7

806

240

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

307.7

613

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

+∞

307.7

563

WF004

NOMESCO Finland

Palliative radiotherapy

1359.8

307.7

647

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

89.4

307.7

301

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

10.6

307.7

442

336

ZX070

NOMESCO Finland

Intensity modified radiotherapy

677.1

307.7

502

A06AH03

ATC

naloxegol; oral

26.5

307.7

682

210

JFB46

NOMESCO Finland

Resection of sigmoid colon

10.2

307.7

545

434

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

307.7

869

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

1405.3

307.7

3498

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

307.7

481

A04AA55

ATC

palonosetron, combinations; systemic

8276.6

307.7

1003

R4190

NOMESCO Finland

Nutritional therapy

8.9

307.7

1346

1268

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

2953.4

307.7

375

L01BC59

ATC

trifluridine, combinations; systemic

+∞

307.7

439

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

42.9

307.7

833

160

JGB04

NOMESCO Finland

Laparoscopic partial proctectomy with partial excision of mesorectum

131.6

307.7

247

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

21.1

307.7

297

113

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

84.4

307.7

480

JN3BD

NOMESCO Finland

Extensive abdominal CT

4.1

307.7

3194

7004

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

7.2

307.7

704

793

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

401.4

307.7

1414

L03AA02

ATC

filgrastim; parenteral

104.6

307.7

910

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

7.6

307.7

1572

1748

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

307.7

457

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

140.0

307.7

297

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

307.7

3807

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

30.9

307.7

377

WF001

NOMESCO Finland

Preoperative radiotherapy

4662.3

307.7

1130

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

716.5

307.7

444

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

82.5

307.7

519

A02BC02

ATC

pantoprazole; systemic

1.9

307.7

13194

81575

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

16.6

307.7

1064

533

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

8.2

307.7

661

659

Y77

ICPC

Malignant neoplasm prostate

213.9

307.7

346

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

4817.6

307.7

2203

R18

ICD-10 Finland

Ascites

8.2

307.7

760

757

JG1BG

NOMESCO Finland

MRI of rectum

170.6

307.7

728

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

21.3

307.7

2617

1115

JFB30

NOMESCO Finland

Right hemicolectomy

49.9

307.7

1452

248

JFB43

NOMESCO Finland

Left hemicolectomy

24.2

307.7

415

138

116

Kela drug reimbursment

Prostate cancer

+∞

307.7

816

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

5.9

307.7

1275

1801

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

2994.4

307.7

380

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

10526.3

307.7

1256

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

9.5

307.7

801

689

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

307.7

889

C16.00

ICD-10 Finland

Cardia

+∞

307.7

354

HAB40

NOMESCO Finland

Wedge excision of mammary gland

16.0

307.7

364

183

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

17.2

307.7

1846

930

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

307.7

388

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

482.1

307.7

2217

TPH07

NOMESCO Finland

Cathetrisation of artery

4.5

307.7

3978

8237

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

307.7

783

JFF10

NOMESCO Finland

Loop enterostomy

38.7

307.7

422

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.2

307.7

3491

13916

L02AE02

ATC

leuprorelin; implant, parenteral

34.0

307.7

557

133

H01CB03

ATC

lanreotide; parenteral

158.7

307.7

297

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

12.1

307.7

875

596

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

10.8

307.7

3450

3020

JAH00

NOMESCO Finland

Laparotomy

8.3

307.7

1277

1294

JFB00

NOMESCO Finland

Partial resection of small intestine

11.8

307.7

916

643

ZX090

NOMESCO Finland

Other technic of radiotherapy

244.3

307.7

600

JN4CD

NOMESCO Finland

Very extensive body CT

19.0

307.7

1950

896

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

257.6

307.7

753

UJG02

NOMESCO Finland

Proctoscopy

6.2

307.7

843

1118

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

14450.9

307.7

1681

WX302

NOMESCO Finland

Thoracal epidural anesthesy

32.5

307.7

4386

1366

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

307.7

691

ZXE30

NOMESCO Finland

More than five and less than seven hours

4.1

307.7

1371

2771

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

307.7

1305

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

307.7

396

JK3BT

NOMESCO Finland

Catherisation of bile duct with X-ray guidance

43.6

307.7

358

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

25.9

307.7

336

104

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

307.7

693

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

1190.1

307.7

577

WZC30

NOMESCO Finland

Teaching

4.6

307.7

4682

9863

UJK02

NOMESCO Finland

ERCP

6.7

307.7

1213

1519

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

4113.9

307.7

1472

JDD00

NOMESCO Finland

Total gastrectomy and Roux-en-Y oesophagojejunostomy

508.8

307.7

380

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

307.7

809

Z93.3

ICD-10 Finland

Colostomy status

45.0

307.7

699

127

K56.7

ICD-10 Finland

Ileus, unspecified

6.1

307.7

661

883

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

+∞

307.7

419

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

22.3

307.7

767

282

PJA12

NOMESCO Finland

Sentinel node biopsy

217.2

307.7

613

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

6.3

307.7

701

912

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

307.7

400

H01CB02

ATC

octreotide; parenteral

73.1

307.7

256

WX408

NOMESCO Finland

General anesthesy, balanced

3.1

307.7

6386

20732

Z51.5

ICD-10 Finland

Palliative care

20.6

307.7

4817

2427

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

307.7

2443

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

19.3

307.7

886

378

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

18.1

307.7

309

137

C61

ICD-10 Finland

Malignant neoplasm of prostate

291.7

307.7

1437

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

646.6

307.7

786

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

6447.6

307.7

792

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

519.6

307.7

451

JFF23

NOMESCO Finland

Transversostomy

67.0

307.7

1121

140

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

11.8

307.7

807

561

JN4AD

NOMESCO Finland

Body CT examination

11.6

307.7

4596

3994

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

307.7

711

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.4

307.7

7318

30699

A04AA02

ATC

granisetron; systemic, transdermal

1225.0

307.7

4696

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

2724.6

307.7

1322

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

18.2

307.7

458

203

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

98.5

307.7

222

WZC00

NOMESCO Finland

Treatment plan or consultation

3.5

307.7

8204

26522

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

3479.6

307.7

439

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

87.0

307.7

1458

143

WF002

NOMESCO Finland

Radical radiotherapy

98.9

307.7

1232

105

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

3133.9

307.7

397

C25.2

ICD-10 Finland

Malignant neoplasm: Tail of pancreas

+∞

307.7

362

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

1232.8

307.7

1445

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

307.7

403

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

6.4

307.7

740

941

JN4BD

NOMESCO Finland

Extensive body CT

17.2

307.7

5465

3416

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

50.4

307.7

920

151

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

9.0

307.7

567

512

L02BA01

ATC

tamoxifen; oral

48.5

307.7

231

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

8.8

307.7

703

655

C15.9

ICD-10 Finland

Malignant neoplasm: Oesophagus, unspecified

1507.5

307.7

390

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

307.7

492

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

304.3

307.7

378

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

+∞

307.7

405

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

3694.3

307.7

465

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

17.9

307.7

1070

498

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

307.7

702

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.6

307.7

2948

9840

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

602.7

307.7

375

H02AB02

ATC

dexamethasone; systemic

84.6

307.7

5649

742

HAC20

NOMESCO Finland

Total mastectomy

98.8

307.7

296

C20

ICD-10 Finland

Malignant neoplasm of rectum

3501.0

307.7

1270

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

199.0

307.7

1250

A79

ICPC

Malignancy NOS

169.1

307.7

602

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

7179.8

307.7

1680

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

10.9

307.7

1335

1027

B01AB04

ATC

dalteparin; parenteral

3.9

307.7

1498

3224

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

16.0

307.7

1204

632

A04AD12

ATC

aprepitant; systemic

1406.7

307.7

666

TJF80

NOMESCO Finland

Ostomy education

40.9

307.7

776

156

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

305.8

307.7

417

ZXC96

NOMESCO Finland

Robot assisted procedure

12.9

307.7

429

267

ZX120

NOMESCO Finland

Intravenous

4.3

307.7

2555

5269

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

307.7

1090

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

10185

115

Kela drug reimbursment

Breast cancer

+∞

307.7

627

ZXE20

NOMESCO Finland

More than three and less than five hours

3.1

307.7

3580

10356

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

307.7

350

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

26.3

307.7

643

199

XX3DW

NOMESCO Finland

Time consuming IT work

7.6

307.7

2681

3173

D75

ICPC

Malignant neoplasm colon/rectum

295.3

307.7

960

WF049

NOMESCO Finland

Radiotherapy of metastasis

1061.8

307.7

1140

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

16384.0

307.7

3403

WX402

NOMESCO Finland

General anaesthesia

3.2

307.7

4781

14226

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

27.1

307.7

361

107

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

54.6

307.7

923

140

N02AA05

ATC

oxycodone; systemic

6.0

307.7

6896

13008

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

124.4

307.7

1198

JCC12

NOMESCO Finland

Thoracoscopic or laparoscopic partial oesophagectomy

1417.6

307.7

368

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

3537.3

307.7

446

K83.1

ICD-10 Finland

Obstruction of bile duct

17.9

307.7

940

434

L01BC06

ATC

capecitabine; oral

+∞

307.7

5861

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.3

307.7

904

1177

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

307.7

347

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

3.6

307.7

1220

2815

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

307.7

407

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.2

307.7

4003

16499

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.7

307.7

1162

2578

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

9.7

307.7

2037

1828

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

3339.5

307.7

422

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

21.0

305.9

271

103

JKA20

NOMESCO Finland

Cholecystectomy

4.2

302.7

905

1770

R4110

NOMESCO Finland

Physiotherapy

1.9

301.8

5346

25564

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

117.1

301.4

191

JK3NB

NOMESCO Finland

Percutaneous transhepatic cholangiography

33.4

299.8

230

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

31.5

299.2

233

SPAT1125

SPAT

Stoma care and guidance

5.8

299.1

608

846

JMA10

NOMESCO Finland

Transabdominal total splenectomy

21.4

295.5

260

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

13.9

293.2

313

181

KCD02

NOMESCO Finland

Transurethral resection of bladder

13.0

293.2

324

200

ZX080

NOMESCO Finland

Image guided radiotherapy

630.9

291.5

315

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

290.4

305

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

284.5

289.1

321

JDE00

NOMESCO Finland

Gastrojejunostomy

69.9

288.7

193

J01MA12

ATC

levofloxacin; systemic

2.0

286.5

3881

16881

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.6

286.1

1947

6335

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

29.2

285.4

227

C25.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of pancreas

+∞

284.6

299

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

283.7

298

8140/3-C16.9

ICD-O-3

Adenocarcinoma, NOS, of stomach, NOS

+∞

283.7

298

L02BB03

ATC

bicalutamide; oral

811.8

282.9

304

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

278.9

293

K83.0

ICD-10 Finland

Cholangitis

6.0

278.8

550

742

8140/3-C16.0

ICD-O-3

Adenocarcinoma, NOS, of cardia, NOS

+∞

278.0

292

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

275.1

289

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

5.8

274.4

555

768

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

274.4

6663

34913

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

10.0

272.0

352

282

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

394.1

270.1

296

JD1EE

NOMESCO Finland

Ultrasound examination of gastro-oesophageal reflux

47.6

268.9

191

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

2211.6

267.9

284

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

5.1

267.4

619

975

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

13.3

266.4

290

174

Z93

ICD-10 Finland

Artificial opening status

37.6

265.5

198

D76

ICPC

Malignant neoplasm pancreas

332.8

264.7

292

A06AD11

ATC

lactulose; oral

2.0

264.2

3471

14883

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

+∞

263.6

277

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

38.7

261.8

194

B03BA03

ATC

hydroxocobalamin; parenteral

2.7

261.7

1584

4847

JAL30

NOMESCO Finland

Omentectomy

16.5

261.4

256

124

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

8.5

260.6

378

356

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

42.6

257.7

187

JJB10

NOMESCO Finland

Atypcal resection of liver

282.6

255.7

284

TPX15

NOMESCO Finland

Removal of vascular injection port

21.8

250.7

219

C18.51

ICD-10 Finland

Malignant tumor of flexura hiealis invasive carcinoma

+∞

250.3

263

C16.0

ICD-10 Finland

Malignant neoplasm: Cardia

+∞

250.3

263

JLC10

NOMESCO Finland

Distal pancreatectomy

32.0

248.9

193

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

6.7

248.9

439

525

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

48.3

248.5

176

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

708.8

246.8

266

C24.9

ICD-10 Finland

Malignant neoplasm: Biliary tract, unspecified

+∞

246.5

259

8070/3-C15.9

ICD-O-3

Squamous cell carcinoma, NOS, of esophagus, NOS

+∞

241.7

254

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.1

240.6

1151

3087

SPAT1109

SPAT

Analgesia with portable analgesic pump

14.2

240.6

253

142

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.1

240.0

1124

2977

K92.1

ICD-10 Finland

Melaena

2.7

239.2

1434

4360

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

236.7

2128

7836

L03AA14

ATC

lipegfilgrastim; parenteral

1944.5

236.5

251

Z43.3

ICD-10 Finland

Attention to colostomy

39.4

234.4

173

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

234.2

6435

34545

ZZR00

NOMESCO Finland

Flap of skin

9.1

233.5

323

285

JFB54

NOMESCO Finland

Laparoscopic resection of sigmoid colon with partial proctectomy

40.0

232.6

171

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

21.5

227.9

200

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

396.9

227.2

249

C16.09

ICD-10 Finland

Malignant tumor of cardiac or other unspecified carcinoma

+∞

225.5

237

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

224.5

236

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

7.2

223.7

373

418

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

10.1

221.7

285

226

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

82.3

221.2

145

JGB31

NOMESCO Finland

Laparoscopic and perineal excision of rectum

248.6

220.8

247

Z51.0

ICD-10 Finland

Radiotherapy session

322.2

220.0

243

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

15.1

218.4

223

118

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

216.9

228

Z31.5

ICD-10 Finland

Genetic counselling

3.8

216.0

719

1520

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.4

216.0

595

1088

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.7

216.0

1280

3863

8145/3-C16.9

ICD-O-3

Carcinoma, diffuse type of stomach, NOS

+∞

215.0

226

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

214.0

225

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

10.9

213.1

260

190

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

7.9

211.7

324

327

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

106.5

209.7

134

C16.2

ICD-10 Finland

Malignant neoplasm: Body of stomach

+∞

208.3

219

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

208.3

219

E34.0

ICD-10 Finland

Carcinoid syndrome

209.0

208.2

235

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

6.1

207.7

403

534

C18.02

ICD-10 Finland

Malignant tumor of caecum carcinoma of adenoma

+∞

207.4

218

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

3.9

206.3

680

1427

C18.10

ICD-10 Finland

Malignant tumor of the appendix without histology

1678.3

205.1

218

C18.9

ICD-10 Finland

Malignant neoplasm: Colon, unspecified

+∞

204.5

215

1XC07, ,

NOMESCO Finland

1670.3

204.1

217

C15.4

ICD-10 Finland

Malignant neoplasm: Middle third of oesophagus

873.4

204.0

219

C18.22

ICD-10 Finland

Malignant tumor of the colon ascending carcinoma of the adenoma

+∞

203.5

214

198

Kela drug reimbursment

Sorafenib

+∞

202.6

213

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

32.7

202.2

156

JK4ZT

NOMESCO Finland

Percutaneous transhepatic implantation of bile duct prothesis

296.5

202.1

224

ZX121

NOMESCO Finland

Central venous catheter

27.2

202.0

164

JFB50

NOMESCO Finland

Other resection of colon

21.4

201.1

177

ZXE40

NOMESCO Finland

More than seven and less than nine hours

4.3

200.8

580

1101

JWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery

28.7

199.1

159

C17.2

ICD-10 Finland

Malignant neoplasm: Ileum

1622.0

198.4

211

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

30.3

198.2

156

WX704

NOMESCO Finland

Intubation

2.4

198.1

1553

5366

C18.19

ICD-10 Finland

Malignant tumor in appendix other or unspecified histology

+∞

197.8

208

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

197.8

208

ZXD05

NOMESCO Finland

Urgent procedure

1.7

196.8

5572

29851

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

78.8

195.7

129

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.8

195.6

1087

3166

8140/3-C18.6

ICD-O-3

Adenocarcinoma, NOS, of descending colon

+∞

195.0

205

C18.91

ICD-10 Finland

Malignant tumor of unspecified location in colon invasive carcinoma

+∞

194.0

204

8140/3-C18.3

ICD-O-3

Adenocarcinoma, NOS, of hepatic flexure of colon

+∞

192.1

202

C16.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of stomach

+∞

192.1

202

HA1AA

NOMESCO Finland

X-ray mammography

3.6

189.8

691

1555

8140/3-C25.0

ICD-O-3

Adenocarcinoma, NOS, of head of pancreas

+∞

188.3

198

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

239.7

186.5

209

XX1AD

NOMESCO Finland

Other CT-examination

62.6

185.5

126

8000/3-C22.0

ICD-O-3

Neoplasm, malignant of liver

+∞

185.4

195

JN6AD

NOMESCO Finland

CT of torso and neck

8.6

184.6

265

246

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.5

184.5

1324

4386

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.8

183.2

1012

2936

C23

ICD-10 Finland

Malignant neoplasm of gallbladder

+∞

182.6

192

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

73.9

182.2

121

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

61.6

182.1

124

JFB40

NOMESCO Finland

Resection of transverse colon

37.3

182.0

136

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

11.4

181.9

216

151

C18

ICD-10 Finland

Malignant neoplasm of colon

+∞

180.7

190

C50.99

ICD-10 Finland

Breast, unspecified

519.9

180.4

196

A98

ICPC

Health maint/preventive medicine

0.6

180.2

14829

129215

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

40.3

179.8

132

C18.50

ICD-10 Finland

Malignant tumor in flexural lienalis without histology

+∞

179.7

189

N02AA01

ATC

morphine; systemic, rectal

5.0

178.6

419

667

Z43.2

ICD-10 Finland

Attention to ileostomy

38.8

178.3

132

8160/3-C22.1

ICD-O-3

Cholangiocarcinoma of intrahepatic bile duct

+∞

176.9

186

C16.23

ICD-10 Finland

Malignant tumor of the corpus ventriculi diffuse carcinoma

+∞

176.9

186

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

10.2

176.6

225

176

L01BC53

ATC

tegafur, combinations; systemic

+∞

175.9

185

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

19.8

175.4

159

JK3NT

NOMESCO Finland

Percutaneous transhepatic dilatation of bileducts

38.2

175.0

130

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.9

174.5

892

2478

N02AX02

ATC

tramadol; systemic, rectal

1.6

174.4

7999

47752

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.6

173.4

1106

3457

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.0

173.0

851

2313

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

+∞

171.1

180

R11

ICD-10 Finland

Nausea and vomiting

2.2

171.0

1642

6175

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

9.1

170.6

235

206

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.9

169.5

884

2483

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

80.1

168.7

111

TJA10

NOMESCO Finland

Laparocentesis

31.5

168.3

131

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

168.2

6671

38452

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

8.6

167.7

241

224

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

64.1

166.9

113

ZX050

NOMESCO Finland

Stereotactic radiotherapy

25.5

166.6

138

JK3FT

NOMESCO Finland

Exchange of bile duct catheter with radiological guidance

40.4

166.2

122

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

163.5

172

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

1441.6

163.2

174

JFH00

NOMESCO Finland

Total colectomy and ileorectal anastomosis

20.0

161.9

146

8140/3-C15.9

ICD-O-3

Adenocarcinoma, NOS, of esophagus, NOS

+∞

161.6

170

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

6.1

161.4

311

409

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.4

161.0

1194

4010

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

160.7

169

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

160.7

169

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

159.6

2050

8599

UJF30

NOMESCO Finland

Ileoscopy through colon

2.0

159.4

1964

8117

JKE22

NOMESCO Finland

Endoscopic extraction of foreign body from bile duct

9.4

159.3

214

181

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

158.8

167

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

70.1

158.5

106

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

3.9

158.3

506

1037

JDC20

NOMESCO Finland

Partial gastrectomy and Roux-en-Y reconstruction

38.7

157.9

117

C16.20

ICD-10 Finland

Malignant tumor of the corpus ventriculi without histology

+∞

156.9

165

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

14.6

156.6

162

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

1366.2

155.6

166

C18.4

ICD-10 Finland

Malignant neoplasm: Transverse colon

+∞

154.9

163

JF2AB

NOMESCO Finland

Colongraphy with X-ray

17.9

154.6

146

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

6.4

153.6

280

347

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

30.7

153.1

120

JJB50

NOMESCO Finland

Excision of segments V, VI, VII and VIII of liver

269.0

152.8

170

8240/3-C17.9

ICD-O-3

Neuroendocrine tumor, NOS, of small intestine, NOS

+∞

151.1

159

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.8

150.5

810

2313

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

4.5

150.2

398

704

8240/3-C18.1

ICD-O-3

Neuroendocrine tumor, NOS, of appendix

+∞

150.2

158

L01XE21

ATC

[U] regorafenib

+∞

150.2

158

V03AF03

ATC

calcium folinate; systemic

434.0

150.2

164

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

5.6

150.0

314

449

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.8

149.7

842

2463

L01AX03

ATC

temozolomide; systemic

1300.7

149.0

159

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

57.8

148.3

102

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

12.2

146.4

167

109

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

27.0

146.3

119

JGB37

NOMESCO Finland

Laparoscopic wide excision of rectum

627.8

146.2

158

JJA20

NOMESCO Finland

Open biopsy of liver

18.5

145.1

135

WX002

NOMESCO Finland

Sedation and analgesia

1.7

145.0

3629

18593

ZX112

NOMESCO Finland

Subcutaneous

6.4

144.7

265

330

C16.3

ICD-10 Finland

Malignant neoplasm: Pyloric antrum

+∞

144.5

152

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.0

144.3

715

1949

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

143.5

151

JDC10

NOMESCO Finland

Partial gastrectomy and gastrojejunostomy

52.9

143.4

100

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

3.8

143.2

478

1011

B81

ICPC

Anaemia vit B12/folate deficiency

2.6

143.1

935

2953

JN7AQ

NOMESCO Finland

Somatostatin receptor SPET med low dose CT

145.9

142.8

165

8240/3-C18.2

ICD-O-3

Neuroendocrine tumor, NOS, of ascending colon

+∞

142.6

150

WPB10

NOMESCO Finland

Making a convalescent care decision

20.6

142.4

127

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

141.6

149

XX7JT

NOMESCO Finland

Somatostatin isotope ablative therapy

+∞

140.7

148

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

603.7

140.5

152

L02BG03

ATC

anastrozole; oral

42.6

140.5

102

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

20.0

139.8

126

L01EX05

ATC

regorafenib; oral

+∞

139.7

147

C16.39

ICD-10 Finland

Malignant tumor of the antrum ventriculi other or unspecified carcinoma

+∞

139.7

147

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.9

138.7

450

932

D99

ICPC

Disease digestive system other

5.3

137.6

302

452

Z93.2

ICD-10 Finland

Ileostomy status

11.8

137.5

160

108

JFB20

NOMESCO Finland

Ileocaecal resection

9.4

137.4

184

155

SPAT1262

SPAT

Handing over of treatment supplies

1.7

136.9

3529

18185

C18.1

ICD-10 Finland

Malignant neoplasm: Appendix

+∞

136.9

144

8000/3-C25.0

ICD-O-3

Neoplasm, malignant of head of pancreas

+∞

136.9

144

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

136.9

144

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

587.6

136.7

148

C10AA07

ATC

rosuvastatin; oral

0.6

136.6

3251

38066

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.0

136.4

672

1825

C16.30

ICD-10 Finland

Malignant tumor of the antrum ventriculi without histology

+∞

135.9

143

JN2CM

NOMESCO Finland

Lower part of abdomen extensive MRI examination with Tesla magnet

18.7

135.0

125

C16.29

ICD-10 Finland

Malignant tumor of the corpus ventriculi other or unspecified carcinoma

+∞

135.0

142

JN4DD

NOMESCO Finland

Scout CT scan of torso

60.8

134.8

JGB36

NOMESCO Finland

Wide excision of rectum

1162.3

134.8

144

JFF27

NOMESCO Finland

Laparoscopic sigmoidostomy

37.8

134.2

100

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

8.0

134.1

203

202

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.6

134.1

349

608

JFB53

NOMESCO Finland

Resection of sigmoid colon with partial proctectomy

49.7

133.3

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.0

133.2

409

813

8140/3-C15.5

ICD-O-3

Adenocarcinoma, NOS, of lower third of esophagus

+∞

133.1

140

8500/3-C25.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of pancreas, NOS

+∞

132.1

139

WW200, ,

SPAT

0.5

131.0

1779

24236

JDA55

NOMESCO Finland

Endoscopic dilatation of stomach, pylorus or anastomosis of stomach

15.4

130.9

132

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

6.0

130.6

255

340

WX892

NOMESCO Finland

Monitored bed care

2.0

130.4

1511

6088

Z3231

NOMESCO Finland

Registered nurse

1.6

130.3

4648

25845

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

16.0

130.2

129

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

12.9

130.1

144

UJC12

NOMESCO Finland

Flexible oesophagoscopy

6.1

129.9

248

323

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

3.0

129.3

639

1738

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.1

128.8

587

1523

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

147.1

128.2

148

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

6.5

127.4

230

282

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

3.5

126.8

482

1115

JFF24

NOMESCO Finland

Laparoscopic transversostomy

50.4

126.5

JJB71

NOMESCO Finland

Laparoscopic resection of liver

364.3

125.6

138

JL1AT

NOMESCO Finland

Biopsy of pancreas with ultrasound guidance

225.2

125.5

141

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

125.4

132

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

4.2

124.7

366

703

E0000UV, ,

ATC

1.5

124.6

6853

41608

8480/3-C20.9

ICD-O-3

Mucinous adenocarcinoma of rectum, NOS

+∞

124.5

131

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

124.5

131

8140/3-C18.5

ICD-O-3

Adenocarcinoma, NOS, of splenic flexure of colon

+∞

123.5

130

JJB30

NOMESCO Finland

Excision of two segments of liver

185.5

123.3

140

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

+∞

122.6

129

C17.0

ICD-10 Finland

Malignant neoplasm: Duodenum

+∞

122.6

129

T73

ICPC

Neoplasm endocrine other/unspecified

46.0

121.6

ZXE00

NOMESCO Finland

One hour or less

1.5

121.4

6349

38123

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

65.0

121.3

UJF34

NOMESCO Finland

Left colonoscopy

6.3

120.7

224

283

C15.1

ICD-10 Finland

Malignant neoplasm: Thoracic part of oesophagus

+∞

120.7

127

C16.04

ICD-10 Finland

Malignant tumor of cardiac intestinal carcinoma

+∞

120.7

127

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.6

120.2

739

2261

178

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

+∞

119.7

126

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

2.9

119.0

605

1672

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.5

118.9

794

2531

C50

ICD-10 Finland

Malignant neoplasm of breast

177.5

117.7

134

D74

ICPC

Malignant neoplasm stomach

258.4

117.6

131

L01XE05

ATC

[U] sorafenib

+∞

116.9

123

C25.4

ICD-10 Finland

Malignant neoplasm: Endocrine pancreas

+∞

116.9

123

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

10.0

116.0

149

118

C16.03

ICD-10 Finland

Malignant tumor of cardiac diffuse carcinoma

+∞

115.9

122

C16.4

ICD-10 Finland

Malignant neoplasm: Pylorus

+∞

115.9

122

J01MA02

ATC

ciprofloxacin; systemic

1.4

115.8

6963

42833

C25

ICD-10 Finland

Malignant neoplasm of pancreas

254.4

115.7

129

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.6

115.6

1769

23401

8480/3-C18.0

ICD-O-3

Mucinous adenocarcinoma of cecum

+∞

115.0

121

8240/3-C17.2

ICD-O-3

Neuroendocrine tumor, NOS, of ileum

+∞

115.0

121

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

15.5

114.2

115

JN3GE

NOMESCO Finland

Intraoperative ultrasound examination of abdomen

491.4

114.0

124

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

11.6

113.4

133

8480/3-C18.1

ICD-O-3

Mucinous adenocarcinoma of appendix

+∞

113.1

119

C16.33

ICD-10 Finland

Malignant tumor of the antrum ventriculi diffuse carcinoma

+∞

113.1

119

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

4.9

113.0

272

443

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.4

112.7

437

1024

KC1GB

NOMESCO Finland

Cystography with X-ray

16.6

112.0

109

WX004

NOMESCO Finland

Patient-controlled sedation

6.9

111.5

191

221

C26.0

ICD-10 Finland

Malignant neoplasm: Intestinal tract, part unspecified

+∞

111.2

117

C15.3

ICD-10 Finland

Malignant neoplasm: Upper third of oesophagus

944.4

111.0

119

WX610

NOMESCO Finland

Patient controlled analgesia

7.6

110.5

174

182

C16.24

ICD-10 Finland

Malignant tumor of the corpus ventriculi intestinal carcinoma

+∞

110.2

116

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

4.5

110.0

290

511

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

8.3

109.7

161

154

JCC10

NOMESCO Finland

Transthoracic partial oesophagectomy without interposition

127.1

109.7

128

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

109.5

1372

5672

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

16.8

109.4

106

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

109.3

115

JFF26

NOMESCO Finland

Sigmoidostomy

19.6

109.0

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

36.1

108.9

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

4.9

108.5

261

425

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

108.3

114

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

920.4

108.2

116

L02AE04

ATC

triptorelin; parenteral

50.2

107.9

K65.0

ICD-10 Finland

Acute peritonitis

4.3

107.7

306

573

JFC00

NOMESCO Finland

Entero-enterostomy

24.6

107.4

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

28.4

107.3

C24.1

ICD-10 Finland

Malignant neoplasm: Ampulla of Vater

+∞

106.4

112

C24.0

ICD-10 Finland

Malignant neoplasm: Extrahepatic bile duct

+∞

106.4

112

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

106.4

112

JLC11

NOMESCO Finland

Laparoscopic distal pancreatectomy

31.3

106.4

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

53.3

106.1

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.3

105.9

881

3104

C21.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of rectum, anus and anal canal

+∞

105.5

111

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

104.5

110

C16.34

ICD-10 Finland

Malignant tumor of the antrum ventriculi intestinal carcinoma

+∞

104.5

110

8240/3-C20.9

ICD-O-3

Neuroendocrine tumor, NOS, of rectum, NOS

+∞

104.5

110

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

32.1

104.5

189

Kela drug reimbursment

Imatinib

888.4

104.4

112

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

15.6

103.6

104

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

880.4

103.5

111

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

102.6

108

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

102.6

108

323

Kela drug reimbursment

Sorafenib

+∞

102.6

108

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

3.4

102.2

394

920

M01AH05

ATC

etoricoxib; oral

0.7

101.9

7251

69664

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

101.7

2869

15000

C18.6

ICD-10 Finland

Malignant neoplasm: Descending colon

+∞

101.7

107

XJA00

NOMESCO Finland

Intraoperative abdominal ultrasonography

227.4

101.6

114

JFF13

NOMESCO Finland

Terminal enterostomy

11.9

101.3

117

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.6

101.3

358

788

WPA16

NOMESCO Finland

Extensive demanding palliative symptom assessment and treatment

51.1

101.1

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

435.4

100.8

110

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

100.7

106

C18.39

ICD-10 Finland

Malignant tumor of flexura hepatica other or unspecified histology

+∞

100.7

106

S77

ICPC

Malignant neoplasm of skin

15.4

100.2

101

C10AX09

ATC

ezetimibe; oral

0.5

99.8

1288

17989

C18.3

ICD-10 Finland

Malignant neoplasm: Hepatic flexure

848.5

99.7

107

JFB33

NOMESCO Finland

Other resection comprising small intestine and colon

15.7

99.1

C03CA01

ATC

furosemide; systemic

1.4

98.9

6343

39174

C15.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of oesophagus

+∞

98.8

104

L02BX02

ATC

degarelix; parenteral

+∞

98.8

104

WX882

NOMESCO Finland

High dependency care

2.8

98.8

554

1615

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

149.5

98.1

113

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.9

97.8

506

1412

JDA63

NOMESCO Finland

Local excision of lesion of stomach

18.8

97.4

KA1FN

NOMESCO Finland

Isotope renography

7.6

97.2

153

160

SPAT1255

SPAT

Intravenous administration of medicine

1.9

97.0

1274

5347

8140/3-C23.9

ICD-O-3

Adenocarcinoma, NOS, of gallbladder

+∞

96.9

102

WGA11

NOMESCO Finland

Planning of pain management

8.8

96.6

136

123

Z3226

NOMESCO Finland

Physiotherapist

1.6

96.4

2993

15985

WPA13

NOMESCO Finland

Palliative consultation

12.1

96.3

110

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

7.3

95.7

155

168

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

95.4

936

3529

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

24.4

95.2

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

37.5

95.1

1CD01, ,

NOMESCO Finland

+∞

95.0

100

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

95.0

100

M25.5

ICD-10 Finland

Pain in joint

0.6

94.9

2655

30488

128

Kela drug reimbursment

Cancers of female genital organs

276.0

94.6

105

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

273.4

93.7

104

PC2DT

NOMESCO Finland

Embolisation of lesion of liver

403.4

93.3

102

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

7.6

93.1

146

152

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

29.3

93.1

D37.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Appendix

11.1

93.1

112

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

93.1

8480/3-C18.2

ICD-O-3

Mucinous adenocarcinoma of ascending colon

+∞

93.1

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

92.8

1405

6177

6434

FHL

Anterior resection

18.4

92.3

8140/3-C26.9

ICD-O-3

Adenocarcinoma, NOS, of gastrointestinal tract, NOS

+∞

92.1

C15.0

ICD-10 Finland

Malignant neoplasm: Cervical part of oesophagus

+∞

92.1

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

92.1

C18.42

ICD-10 Finland

Malignant tumor of the transverse colon carcinoma of the adenoma

+∞

92.1

6404

FHL

Hemicolectomy on the right

19.0

91.3

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

91.2

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

776.7

91.2

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

776.7

91.2

C18.49

ICD-10 Finland

Malignant tumor of the transverse colon other or unspecified histology

776.7

91.2

JGB01

NOMESCO Finland

Laparoscopic partial proctectomy and colorectal or coloanal anastomosis

96.1

91.1

109

PC2ET

NOMESCO Finland

Extensive embolisation of lesion of liver

768.7

90.2

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

8.5

89.8

129

120

JFF00

NOMESCO Finland

Catheter enterostomy

42.9

89.5

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

387.4

89.5

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

46.1

89.4

JJB60

NOMESCO Finland

Other excsion of three or more segments of liver

760.7

89.3

A28

ICPC

Limited function/disability NOS

1.5

89.2

3323

18436

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

6.7

89.1

156

185

X76

ICPC

Malignant neoplasm breast female

117.9

88.6

104

A41.8

ICD-10 Finland

Other specified sepsis

3.1

87.5

404

1056

8160/3-C24.9

ICD-O-3

Cholangiocarcinoma of billiary tract, NOS

+∞

87.4

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

87.4

K43.5

ICD-10 Finland

Parastomal hernia without obstruction or gangrene

31.7

87.4

D18

ICPC

Change in faeces/bowel movements

2.8

87.1

477

1373

WPA45

NOMESCO Finland

Continuous drug infusion in palliative care

24.1

86.5

JG1DG

NOMESCO Finland

Very extensive MRI of rectum

91.7

86.5

104

SAA01

NOMESCO Finland

Simple examination of mouth

0.7

86.3

8547

78943

A41.9

ICD-10 Finland

Sepsis, unspecified

2.3

85.9

701

2447

K22.2

ICD-10 Finland

Oesophageal obstruction

4.2

85.2

249

477

SAA02

NOMESCO Finland

Basic examination of mouth

0.7

85.0

7359

69424

JFB51

NOMESCO Finland

Other laparoscopic resection of colon

36.2

85.0

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

11.3

84.8

101

Z85.0

ICD-10 Finland

Personal history of malignant neoplasm of digestive organs

9.3

84.6

114

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

363.5

83.9

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.3

83.6

671

2325

1541A

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,INVASIIVINEN KARSINOOMA]

+∞

83.6

C24.09

ICD-10 Finland

Biliary duct or passage NOS

+∞

83.6

L01XE01

ATC

[U] imatinib

+∞

83.6

UKC02

NOMESCO Finland

Cystoscopy

1.5

82.8

2692

14479

6322

FHL

Gastrectomy (including Roux-Y)

43.2

82.7

C18.62

ICD-10 Finland

Malignant tumor of the descending colon carcinoma of the adenoma

+∞

82.6

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

704.9

82.6

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.3

82.0

687

2425

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

81.7

C17.1

ICD-10 Finland

Malignant neoplasm: Jejunum

+∞

81.7

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

81.3

1202

5239

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

4.0

80.9

246

486

WX725

NOMESCO Finland

Noninvasive ventilation

2.1

80.8

894

3525

KCC10

NOMESCO Finland

Cystoprostatectomy

236.6

79.6

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

9.1

78.9

108

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

13.5

78.9

8500/3-C25.0

ICD-O-3

Infiltrating duct carcinoma, NOS, of head of pancreas

+∞

78.8

L01CB01

ATC

etoposide; systemic

+∞

78.8

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

25.7

78.7

TQW99

NOMESCO Finland

Other minor procedure on skin

2.3

78.6

646

2262

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

14.0

78.5

JFA70

NOMESCO Finland

Suture of small intestine

8.4

78.3

114

108

C24.00

ICD-10 Finland

Hepatic duct

+∞

77.9

C17.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of small intestine

+∞

77.9

8936/3-C16.9

ICD-O-3

Gastrointestinal stromal tumor of stomach, NOS

+∞

77.9

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

13.7

77.7

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.7

77.6

4721

47279

M79.6

ICD-10 Finland

Pain in limb

0.7

77.4

4422

44740

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

76.9

8000/3-C80.9

ICD-O-3

Neoplasm, malignant of unknown primary site

+∞

76.9

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

76.9

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.2

76.8

332

834

JFF30

NOMESCO Finland

Other colostomy

18.7

76.8

8000/3-C24.9

ICD-O-3

Neoplasm, malignant of billiary tract, NOS

+∞

76.0

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

76.0

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.1

75.8

810

3152

SPAT1088

SPAT

Blood transfusion

6.5

75.8

136

166

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

4.1

75.7

228

447

JGA73

NOMESCO Finland

Transanal excision of lesion of rectum

9.1

75.7

104

JFC20

NOMESCO Finland

Other enterocolostomy

31.1

75.4

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

7.6

75.4

119

125

JN2DM

NOMESCO Finland

Lower part of abdomen very extensive MRI examination with Tesla magnet

16.3

75.3

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

75.3

881

3545

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

75.0

C24.02

ICD-10 Finland

Common bile duct

+∞

75.0

Z2221

NOMESCO Finland

Medical doctor

1.4

75.0

4111

24456

K45.8

ICD-10 Finland

Other specified abdominal hernia without obstruction or gangrene

5.4

74.8

160

234

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

27.9

74.4

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.4

74.1

575

1962

JJB20

NOMESCO Finland

Excision of single segment of liver

633.2

74.1

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

74.1

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

74.1

UJD02

NOMESCO Finland

Gastroscopy

2.0

73.7

909

3726

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

625.2

73.2

C18.5

ICD-10 Finland

Malignant neoplasm: Splenic flexure

+∞

73.1

8480/3-C18.7

ICD-O-3

Mucinous adenocarcinoma of sigmoid colon

+∞

73.1

JA3CT

NOMESCO Finland

Cathetrisation of abdominal cavity with CT guidance

17.6

72.7

JG1CM

NOMESCO Finland

Extensive MRI of rectum (more than 1.5 T)

112.3

72.2

SDA03

NOMESCO Finland

Periodontal treatment

0.7

72.1

3704

38261

A10AB05

ATC

insulin aspart; parenteral

1.7

72.1

1385

6523

OAB43, ,

SPAT

0.5

72.0

894

12733

K56.0

ICD-10 Finland

Paralytic ileus

3.7

71.8

244

523

TQW20

NOMESCO Finland

Tatoe

17.1

71.7

PHN73

NOMESCO Finland

Reconstruction of superior mesenteric or portal vein

609.3

71.3

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

71.2

8144/3-C16.9

ICD-O-3

Adenocarcinoma, intestinal type of stomach, NOS

+∞

71.2

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

71.2

8144/3-C16.0

ICD-O-3

Adenocarcinoma, intestinal type of cardia, NOS

+∞

71.2

ZXC40

NOMESCO Finland

Use of ultrasound

6.3

70.9

131

165

JEA00

NOMESCO Finland

Appendectomy

2.0

70.7

852

3463

D13.6

ICD-10 Finland

Benign neoplasm: Pancreas

4.7

70.3

175

294

C16.01

ICD-10 Finland

Malignant tumor in cardia early diffuse gastric carcinoma early diffuse gastric carcinoma

+∞

70.3

8140/3-C24.1

ICD-O-3

Adenocarcinoma, NOS, of ampulla of Vater

+∞

70.3

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

95.1

70.2

KAC10

NOMESCO Finland

Total nephrectomy with capsule

14.5

70.2

Z2446

NOMESCO Finland

Social worker

1.9

70.0

897

3724

N05BA06

ATC

lorazepam; systemic, sublingual

1.9

70.0

920

3853

Z01.2

ICD-10 Finland

Dental examination

0.7

69.8

4390

43937

WVA20

NOMESCO Finland

Medicine administration

2.6

69.6

441

1368

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

4.4

69.6

190

345

K92.0

ICD-10 Finland

Haematemesis

2.4

69.5

509

1692

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

69.3

191

Kela drug reimbursment

Erlotinib

+∞

69.3

GDC00

NOMESCO Finland

Lobectomy of lung

13.6

69.1

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

7.2

69.1

113

124

JWW96

NOMESCO Finland

Other reoperation in gastroenterological surgery

10.5

69.0

M03BX02

ATC

tizanidine; oral

0.8

68.6

7395

68524

C18.12

ICD-10 Finland

Malignant tumor of the appendix carcinoma of the adenoma

+∞

68.4

C49.49

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the abdomen other or unspecified tumor

+∞

68.4

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

203.7

68.4

OAA41

NOMESCO Finland

Health check based on individual needs

32.3

68.3

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

15.8

68.3

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

19.6

68.3

J94.8

ICD-10 Finland

Other specified pleural conditions

3.2

68.2

289

717

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

68.1

1224

5654

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

295.5

67.9

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

67.4

N02BE01

ATC

paracetamol; systemic, rectal

1.4

67.3

15738

115637

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

2.9

66.9

338

931

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.7

66.8

2449

26941

L01EX02

ATC

sorafenib; oral

+∞

66.5

C79.6

ICD-10 Finland

Secondary malignant neoplasm of ovary

+∞

66.5

8145/3-C16.2

ICD-O-3

Carcinoma, diffuse type of body of stomach

+∞

66.5

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

66.5

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.9

66.4

209

424

N03AX16

ATC

[U] pregabalin

1.4

66.4

3826

22890

R01AD58

ATC

fluticasone, combinations; nasal

0.6

66.3

1528

18529

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

5.3

66.2

144

214

C10AA05

ATC

atorvastatin; oral

0.8

66.1

5816

55526

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

3.5

66.0

242

547

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

4.7

65.8

165

279

Z94.4

ICD-10 Finland

Liver transplant status

8.0

65.8

C18.69

ICD-10 Finland

Malignant tumor of colon descendens other or unspecified histology

+∞

65.5

C18.59

ICD-10 Finland

Malignant tumor in flexura lienalis other or unspecified histology

+∞

65.5

Y83.2

ICD-10 Finland

Surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

7.1

65.4

108

120

A21

ICPC

Risk factor for malignancy

31.0

65.1

N05CF01

ATC

zopiclone; oral

1.3

64.7

5578

35534

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

553.5

64.7

JAL00

NOMESCO Finland

Biopsy of peritoneum

10.2

64.5

JDW97

NOMESCO Finland

Other laparoscopic operation on stomach or duodenum

27.4

64.1

JGB20

NOMESCO Finland

Partial rectosigmoidectomy and abdominoperineal pull-through anastomosis

118.8

64.1

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

63.9

1885

9879

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

3.6

63.7

224

492

C16

ICD-10 Finland

Malignant neoplasm of stomach

+∞

63.6

197

Kela drug reimbursment

Sunitinib

+∞

63.6

8240/3-C16.9

ICD-O-3

Neuroendocrine tumor, NOS, of stomach, NOS

+∞

63.6

384

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

+∞

63.6

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

63.6

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

63.1

1179

5502

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

99.0

63.0

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.7

63.0

1147

5315

DAB10

NOMESCO Finland

Partial excision of auricle

25.7

62.9

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

537.6

62.8

C82.1

ICD-10 Finland

Follicular lymphoma grade II

537.6

62.8

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.7

62.8

370

1107

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

4.3

62.8

174

320

L03

ICPC

Low back symptom/complaint

0.7

62.7

2440

26596

8140/3-C25.2

ICD-O-3

Adenocarcinoma, NOS, of tail of pancreas

+∞

62.7

8240/3-C25.9

ICD-O-3

Neuroendocrine tumor, NOS, of pancreas, NOS

+∞

62.7

JFA65

NOMESCO Finland

Endoscopic insertion of ileum stent

+∞

62.7

L15

ICPC

Knee symptom/complaint

0.7

62.3

2190

24335

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.8

62.2

208

441

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.7

61.9

4015

40184

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

61.9

1507

7545

SFA20

NOMESCO Finland

Two-surface restoration

0.8

61.7

6470

60527

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

61.7

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

6.8

61.4

106

124

D82

ICPC

Teeth/gum disease

0.7

61.4

3222

33354

KCD10

NOMESCO Finland

Partial cystectomy

33.8

61.3

XJH00

NOMESCO Finland

Transanal ultrasonography

1.8

61.2

928

4069

XF612

NOMESCO Finland

Measurement of central venous pressure

8.5

61.2

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

0.7

61.1

3942

39504

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

36.4

61.0

R83

ICPC

Respiratory infection other

0.6

60.9

1385

16880

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

521.7

60.9

JJ7LT

NOMESCO Finland

Coagulation of focal hepatic lesion under CT guidance

521.7

60.9

C24.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of biliary tract

+∞

60.8

L01EA01

ATC

imatinib; oral

+∞

60.8

L01BC04

ATC

carmofur; oral

+∞

60.8

L02BB04

ATC

enzalutamide; oral

+∞

60.8

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

60.8

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.6

60.8

365

1103

JN2BD

NOMESCO Finland

Extensive CT exmaniation of lower part of abdomen

8.5

60.6

B03XA02

ATC

darbepoetin alfa; parenteral

2.8

60.5

335

970

R03AC02

ATC

salbutamol; inhalant

0.8

60.4

6432

60109

I81

ICD-10 Finland

Portal vein thrombosis

5.7

60.3

122

169

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

59.8

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

59.8

8070/3-C21.0

ICD-O-3

Squamous cell carcinoma, NOS, of anus, NOS

+∞

59.8

SPAT1290

SPAT

Preparation of deceased person

11.9

59.8

R93.2

ICD-10 Finland

Abnormal findings on diagnostic imaging of liver and biliary tract

4.3

59.6

165

303

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

7.8

59.6

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

59.5

961

4297

JJC00

NOMESCO Finland

Allogenic transplantation of liver

9.7

59.4

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

19.4

59.2

L08

ICPC

Shoulder symptom/complaint

0.7

59.2

1984

22279

A10AE04

ATC

insulin glargine; parenteral

1.6

59.1

1745

9140

C18.81

ICD-10 Finland

Malignant overall tumor of the colon invasive carcinoma

+∞

58.9

C18.32

ICD-10 Finland

Malignant tumor of flexura hepatica carcinoma of adenoma

+∞

58.9

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

58.9

JK3SB

NOMESCO Finland

Endoscopic retrorade cholangiography

8.3

58.8

C90.0

ICD-10 Finland

Multiple myeloma

134.6

58.8

G04CA02

ATC

tamsulosin; oral

1.3

58.6

4561

28535

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

80.4

58.4

XX2RW, ,

NOMESCO Finland

5.0

58.3

135

213

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

4.4

58.3

156

279

XW000

NOMESCO Finland

Bone marrow biopsy

2.2

58.1

511

1841

XKD00

NOMESCO Finland

Uroflowmetry

1.5

57.9

2471

13966

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

3.3

57.9

232

556

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

57.9

C26.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of digestive system

+∞

57.9

SPAT1153

SPAT

Removal of sutures

1.3

57.9

5029

31959

R01AD12

ATC

fluticasone furoate; nasal

0.7

57.8

2378

25715

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

0.8

57.5

4631

45039

N02AA03

ATC

hydromorphone; systemic, rectal

9.6

57.4

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

57.1

3266

19448

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

6.2

57.1

107

137

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

57.0

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

57.0

C16.21

ICD-10 Finland

Malignant tumor of the corpus ventriculi early diffuse gastric carcinoma

+∞

57.0

8249/3-C17.9

ICD-O-3

Neuroendocrine tumor, grade 2 of small intestine, NOS

+∞

57.0

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

57.0

316

Kela drug reimbursment

Imatinib

+∞

57.0

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3024

11637

2.25

308.34

3.5

2.7

254.19

240.52

u/l

1.84

2880

10739

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

12854

119708

0.54

308.33

4.2

4.8

4.42

4.56

mmol/l

38.10

11495

110109

(40768804) Tissue Pathology biopsy report

8635

36273

2.59

307.65

2.7

1.7

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

4787

17408

2.56

307.65

2.2

2.6

2.36

2.30

g/l

7.39

4556

15889

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

10297

54320

2.07

307.65

7.9

5.4

1.19

1.21

mmol/l

85.38

9712

48370

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2289

7494

2.60

307.65

9.5

9.0

1.26

1.42

13.22

2280

7438

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

12269

6164

41.53

307.65

7.7

1.5

43.84

2.69

ug/l

17.87

11197

4616

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

8960

37362

2.67

307.65

3.8

2.3

73.75

61.15

u/l

0.86

8589

34040

(3000991) Gas panel - Venous blood

2841

9786

2.51

307.65

8.6

8.2

—

(4035726) Immunohistochemistry procedure

4527

3052

15.00

307.65

1.4

1.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

1450

578

21.33

307.65

5.4

1.7

12.95

4.52

nmol/l

1.49

1430

548

(3002256) Pathology report gross observation

3497

8634

3.68

307.65

1.4

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4910

11866

4.04

307.65

4.5

2.2

18.23

7.68

umol/l

49.55

4528

10205

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

4625

16353

2.62

307.65

2.3

2.7

19.18

22.49

37.65

4051

13676

(3023368) Bacteria identified in Blood by Culture

8514

32084

2.96

307.65

5.5

4.0

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

5306

17291

2.96

307.65

4.9

2.6

0.79

0.82

mmol/l

53.33

5093

15797

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2310

7443

2.65

307.65

9.5

9.1

0.67

0.69

1.56

2302

7394

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7634

35336

2.17

307.65

5.7

2.7

45.17

34.96

u/l

7.93

7371

33106

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

6556

30512

2.05

307.65

2.4

2.3

3.64

2.98

mg/l

49.11

5738

25785

(3027801) Oxygen [Partial pressure] in Arterial blood

3797

14055

2.41

307.65

8.4

7.1

13.78

11.54

kpa

102.34

3663

13355

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3797

14065

2.41

307.65

8.4

7.1

5.14

5.05

kpa

6.88

3668

13375

(3024561) Albumin [Mass/volume] in Serum or Plasma

12433

49728

3.75

307.65

10.4

3.8

32.67

35.46

g/l

307.65

12047

45268

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

333

130

20.55

307.65

2.2

1.1

21.16

14.68

u/ml

4.61

319

115

(3015377) Calcium [Moles/volume] in Serum or Plasma

8140

37062

2.27

307.65

7.6

2.1

2.34

2.35

mmol/l

21.71

7570

30925

(40768441) Liver Pathology biopsy report

795

426

15.32

307.65

1.3

1.4

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

293

30.09

307.65

2.8

2.4

1122.14

3354.43

u/l

0.54

262

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2717

8228

2.87

307.65

1.7

1.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

7406

25227

3.14

307.65

3.2

2.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

11677

49791

3.16

307.65

3.7

2.4

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2153

6613

2.77

307.65

7.5

7.3

24.66

24.84

mmol/l

1.40

2138

6539

(3020779) Urea [Moles/volume] in Serum or Plasma

3144

10636

2.59

307.65

6.1

7.2

9.08

10.95

mmol/l

33.39

3002

10038

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

4989

2344

22.32

307.65

5.5

1.9

4208.99

17.75

u/ml

2.89

4535

1886

(3042936) Bacteria identified in Isolate by Culture

3994

16160

2.20

307.65

2.2

2.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

693

578

9.78

307.65

2.2

1.3

20.54

17.47

ug/l

1.01

678

557

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

919

405

18.75

307.65

6.1

1.3

201.89

78.94

nmol/l

9.58

912

396

(3013826) Glucose [Moles/volume] in Serum or Plasma

12368

71345

2.03

307.65

7.1

4.5

7.08

6.87

mmol/l

21.41

11973

66563

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

13541

57068

3.94

307.65

16.3

3.8

15.28

12.04

umol/l

33.85

13254

53309

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

14776

89907

2.28

307.65

17.9

5.5

114.86

75.78

u/l

290.68

14393

82947

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3392

11380

2.64

307.65

9.0

8.0

115.13

122.66

g/l

85.36

3310

11083

(3033658) Prothrombin time (PT) actual/Normal

7483

27778

2.84

307.65

6.5

3.6

84.72

86.60

8.12

7392

27010

(3003458) Phosphate [Moles/volume] in Serum or Plasma

3837

14999

2.27

307.65

5.1

5.6

1.01

1.04

mmol/l

6.37

3624

13749

(3022217) INR in Platelet poor plasma by Coagulation assay

12328

59426

2.77

307.65

14.9

17.9

1.30

1.34

inr

0.82

3414

16396

(3022145) Colonoscopy Study observation

5077

12085

4.14

307.65

1.5

1.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

5496

8754

6.53

307.65

3.1

2.1

0.20

0.21

g/l

11.74

5267

7891

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1668

3838

3.66

307.65

2.5

3.2

0.31

0.35

u/ml

5.11

888

2279

(3003396) Base excess in Arterial blood by calculation

3792

14053

2.41

307.65

8.4

7.1

0.72

1.29

mmol/l

15.09

3193

11140

(3014111) Lactate [Moles/volume] in Serum or Plasma

3021

10344

2.55

307.65

7.5

6.9

1.34

1.42

mmol/l

2.68

2959

10045

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2345

6184

3.27

307.65

9.5

10.1

—

(3002582) Erythrocytes [#/volume] in Urine

6973

35590

1.86

307.65

3.5

3.1

69.77

97.00

e6/l

1.12

5507

27078

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

5510

21396

2.45

307.65

8.1

2.2

2.48

2.45

mmol/l

67.27

5198

18141

(3016502) Oxygen saturation in Arterial blood

3591

12646

2.53

307.65

8.6

7.5

96.58

95.07

36.91

3487

12162

(3003694) ABO and Rh group [Type] in Blood

5921

26949

2.06

307.65

1.4

1.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3765

9804

3.52

307.65

3.8

2.3

48.49

44.13

u/l

0.17

3394

8280

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

1428

965

12.53

307.65

3.3

2.1

2558.19

11.26

u/ml

2.60

1416

954

(40758558) Short blood count panel - Blood

5681

26180

2.01

307.65

13.4

4.9

—

(3022948) Iron [Moles/volume] in Serum or Plasma

5064

18928

2.51

307.65

2.3

2.6

10.97

12.86

umol/l

50.29

4832

17360

(3044640) Blood type and Crossmatch panel - Blood

9227

32931

3.33

307.65

3.5

2.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

12309

61836

2.58

307.65

17.3

6.4

4.14

4.33

e9/l

11.99

10992

52727

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

3035

1304

21.62

307.65

5.2

1.9

1751.40

21.65

u/ml

7.74

2807

1166

(3014576) Chloride [Moles/volume] in Serum or Plasma

4746

14902

3.01

307.65

9.2

6.7

104.77

104.24

mmol/l

11.13

4741

14890

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

680

581

9.54

307.65

1.3

1.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

11121

60033

2.09

307.65

8.9

5.8

1.20

1.21

mmol/l

106.49

9525

50721

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1549

3433

3.78

307.65

1.5

1.4

192.54

282.86

ug/g

45.30

984

2027

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

12714

118655

0.55

303.55

4.2

4.8

1.41

1.45

mmol/l

20.07

11257

108411

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

13317

122493

0.54

298.09

4.7

5.4

2.55

2.66

mmol/l

36.32

11805

112224

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1925

6123

2.65

296.42

9.9

9.3

24.05

24.47

mmol/l

6.81

1899

5840

(40768797) Stomach Pathology biopsy report

3839

16486

2.05

294.46

1.6

1.2

—

(3030467) Casts [#/volume] in Urine by Automated count

6376

32711

1.80

284.29

3.4

3.0

0.71

0.46

e6/l

5.78

4991

24748

(3018418) pH of Serum or Plasma

6661

34816

1.78

277.37

5.2

3.3

7.40

1.31

1437

6051

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1558

4673

2.77

267.59

2.0

1.9

2.17

2.19

ug/l

0.02

1411

4047

(3037121) Protein [Mass/volume] in Urine

1375

3910

2.91

260.13

5.3

2.6

0.22

0.36

g/l

5.82

989

1384

(36304419) Bacteria [Presence] in Urine

6083

31432

1.77

259.49

3.4

3.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

4167

19596

1.87

238.89

1.9

1.8

—

(3026782) Osmolality of Urine

4786

23639

1.80

233.24

3.3

2.8

538.68

541.71

mosm/kgh2o

0.41

4275

19955

(3019069) Monocytes/100 leukocytes in Blood

8945

52498

1.64

230.16

5.8

6.0

9.05

8.76

10.49

8407

48402

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

12444

114656

0.59

228.87

3.9

4.3

1.32

1.30

mmol/l

2.07

10948

103795

(3018095) Leukocytes [#/volume] in Urine

7409

41489

1.67

228.61

4.1

3.5

126.35

116.23

e6/l

0.30

5679

29247

(3006504) Eosinophils/100 leukocytes in Blood

8895

52220

1.64

227.76

5.5

5.7

2.61

2.98

40.51

8364

48067

(3023183) Ammonium ion [Moles/volume] in Plasma

981

2499

3.21

223.07

3.0

2.6

37.23

33.21

umol/l

4.42

899

2216

(3022096) Basophils/100 leukocytes in Blood

8654

50633

1.63

222.95

5.6

5.7

0.59

0.68

43.31

8122

46536

(3002030) Lymphocytes/100 leukocytes in Blood

9067

53729

1.63

221.35

5.7

5.8

23.21

27.17

184.68

8539

49671

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

248

162

12.23

217.31

2.6

2.0

—

(40768795) Lymph node Pathology biopsy report

248

164

12.08

215.79

1.2

1.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

7959

45861

1.63

215.69

3.0

2.8

153.57

138.08

ug/l

2.98

7374

41738

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1117

3170

2.89

211.05

2.5

1.4

89.84

25.10

u/ml

12.43

1081

2992

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3935

18833

1.82

209.62

2.1

2.0

30.32

30.01

1.97

3857

18236

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3886

18590

1.81

206.98

3.2

2.7

2.68

2.71

e6/l

0.05

2192

10017

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

211

113

14.89

205.40

1.3

1.1

—

(4281824) Cell count and differential, peritoneal fluid

397

531

6.00

202.74

1.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

8783

52382

1.59

202.10

5.9

5.8

—

(3018010) Neutrophils/100 leukocytes in Blood

8844

53065

1.58

196.31

5.5

5.6

60.71

57.78

78.37

8336

49030

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

968

2715

2.91

186.37

2.4

2.5

3.53

3.61

g/l

0.74

940

2572

(3000850) Epithelial cells [#/volume] in Urine

4758

24805

1.68

184.14

2.8

2.5

5.80

4.98

e6/l

3.48

4359

22036

(3027945) Reticulocytes/100 erythrocytes in Blood

3028

13861

1.86

183.42

2.1

1.83

1.77

2.04

2705

11966

(3031040) Bacteria [#/volume] in Urine by Automated count

11980

77856

1.57

180.89

4.9

4.5

2016.01

1552.75

e6/l

0.31

196

1222

(3006315) Basophils [#/volume] in Blood

9218

56564

1.55

179.32

5.4

0.04

e9/l

24.08

7778

48346

(3001604) Monocytes [#/volume] in Blood

9180

56364

1.55

177.37

5.4

0.63

0.61

e9/l

11.67

7744

48210

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

12763

114958

0.63

173.30

6.7

6.4

41.80

40.67

mmol/mol

26.49

11545

105490

(3019198) Lymphocytes [#/volume] in Blood

9348

57919

1.53

170.77

5.5

1.67

1.85

e9/l

10.08

8092

50588

(3013115) Eosinophils [#/volume] in Blood

9381

58449

1.52

164.58

5.6

0.18

0.20

e9/l

29.61

8039

50595

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

13432

119143

0.64

160.23

4.8

5.0

6.25

6.07

mmol/l

37.71

12028

107652

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

620

1477

3.39

156.12

1.2

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1063

3441

2.52

154.85

1.3

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

277

342

6.47

152.49

1.7

2.4

4768.91

2380.38

e6/l

0.38

193

240

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2871

13664

1.77

150.34

1.8

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1710

6923

2.04

146.28

1.6

1.5

—

(3033799) Differential panel - Peritoneal fluid

247

281

7.01

146.22

1.7

2.3

—

(3026008) Bacteria identified in Urine by Culture

6364

37213

1.52

144.77

3.3

3.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2565

11929

1.80

144.69

3.7

3.8

5.65

5.85

kpa

20.80

2486

11569

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3908

20463

1.64

143.16

3.0

2.6

1.26

1.15

e6/l

0.91

2201

11802

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2846

13712

1.75

142.14

1.8

1.7

—

(3012544) pH of Venous blood

2635

12427

1.78

141.60

3.7

3.8

7.39

7.38

0.44

(3002032) Base excess in Venous blood by calculation

2551

11916

1.79

141.58

3.7

3.8

1.86

1.95

mmol/l

0.54

2067

10170

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1911

8224

1.93

137.01

8.4

7.1

24.44

24.60

mmol/l

1.11

1820

7871

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

979

3237

2.46

136.06

1.8

1.7

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

878

2852

2.50

126.55

2.2

80.86

89.75

19.31

867

2713

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

235

299

6.27

125.84

1.6

2.2

10147.82

15566.51

e6/l

0.29

134

154

(3019060) Gas panel - Arterial blood

1959

8729

1.86

125.71

6.2

4.8

—

(3039000) Anion gap in Blood

846

2721

2.52

124.45

8.6

6.7

11.03

11.37

mmol/l

2.40

769

2463

(3018572) Chloride [Moles/volume] in Blood

846

2722

2.52

124.36

8.6

6.7

105.94

104.73

mmol/l

10.36

769

2464

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1353

5358

2.07

122.02

6.7

4.8

1.63

1.64

0.26

1264

5045

(3007930) Methemoglobin/Hemoglobin.total in Blood

1335

5273

2.07

121.21

6.8

4.9

0.89

0.88

0.89

1247

4961

(3023520) Reticulocytes [#/volume] in Blood

2210

10357

1.77

119.89

2.2

69.34

69.25

e9/l

0.03

1679

7858

(3047181) Lactate [Moles/volume] in Blood

1077

3937

2.23

118.91

7.6

5.8

1.46

1.35

mmol/l

2.17

958

3510

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

814

2630

2.51

118.55

2.2

2.4

225.61

192.54

17.26

779

2473

(40768800) Prostate Pathology biopsy report

336

633

4.25

117.32

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1670

7255

1.89

115.44

1.8

1.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

12415

109990

0.69

115.19

4.3

4.7

2.33

2.14

mu/l

0.42

10969

99339

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

557

1522

2.94

111.75

6.0

6.1

11.90

11.94

mg/l

0.07

500

1381

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2432

12018

1.68

108.37

4.9

3.3

—

(3044007) Cell count panel - Peritoneal fluid

209

276

6.03

108.06

1.7

2.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1363

5676

1.96

106.48

3.8

4.2

23.93

24.18

mmol/l

1.59

1332

5521

(3010370) Gastrin [Moles/volume] in Serum or Plasma

141

117

9.57

106.40

2.6

1.6

77.00

45.96

pmol/l

1.31

117

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

522

1420

2.95

105.53

1.2

1.1

1.67

1.51

g/l

10.15

492

1267

(3004809) Band form neutrophils/100 leukocytes in Blood

507

1398

2.91

100.07

2.5

2.9

2.33

1.28

6.06

455

1192

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1964

9354

1.73

99.60

1.4

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1867

8823

1.74

97.20

1.4

1.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3020

33788

0.65

95.70

1.7

1.41

1.35

mmol/l

2.34

2550

27902

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

9883

89886

0.73

94.81

3.6

3.9

14.98

14.95

pmol/l

0.52

8733

80445

(3013005) Retinol [Moles/volume] in Serum or Plasma

198

283

5.57

94.69

1.9

1.5

1.94

2.04

umol/l

0.85

187

265

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1949

9504

1.69

90.20

5.0

3.1

1.22

1.23

mmol/l

6.91

1801

8003

(3024354) Oxygen [Partial pressure] in Venous blood

2021

9984

1.67

88.98

3.3

3.1

4.54

4.52

kpa

0.21

1947

9646

(1761868) Lipid panel - Serum or Plasma

3566

37984

0.68

86.02

3.0

3.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

797

2936

2.19

85.92

1.3

1.2

93.77

140.77

titre

0.75

246

(40768793) Breast Pathology biopsy report

255

514

3.95

81.60

1.3

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

781

2942

2.14

79.56

1.3

1.2

332.22

1031.26

titre

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

515

1623

2.55

78.76

5.7

6.0

924.65

789.95

iu/ml

0.17

246

(3018405) Lactate [Moles/volume] in Arterial blood

1084

4657

1.89

76.53

4.8

4.3

1.41

1.39

mmol/l

0.20

1066

4563

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1636

20016

0.61

74.71

1.2

1.3

45.50

39.67

iu/ml

0.62

518

6337

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1512

18807

0.60

73.89

1.2

1.3

18.02

14.46

u/ml

0.47

538

6846

(3017181) Myelocytes/100 leukocytes in Blood

1800

9069

1.62

72.54

3.3

3.7

1.10

0.79

5.44

898

2379

(3036489) Thrombin time

923

3855

1.93

70.83

2.1

1.9

21.90

21.78

0.22

875

3385

(3026692) Albumin [Mass/volume] in Peritoneal fluid

167

268

4.95

70.67

1.3

1.6

13.38

12.98

g/l

0.20

137

186

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1235

5708

1.76

68.56

1.5

1.6

1.68

1.56

g/l

3.96

1063

4835

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

10556

73093

1.31

68.36

4.7

3.0

110.97

49.33

u/l

144.66

9956

66756

(3003434) Protein [Mass/volume] in Pleural fluid

434

1349

2.57

68.27

1.4

1.5

31.81

29.60

g/l

2.58

390

1175

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1089

4902

1.80

66.06

2.0

1.8

—

(3000963) Hemoglobin [Mass/volume] in Blood

15732

131155

0.71

65.89

46.3

20.1

124.18

136.36

g/l

307.65

15499

128527

(3026361) Erythrocytes [#/volume] in Blood

15731

131138

0.71

65.68

46.0

20.0

4.20

4.50

e12/l

307.65

15286

126110

(3010813) Leukocytes [#/volume] in Blood

15731

131132

0.71

65.56

46.0

20.0

7.08

6.74

e9/l

44.76

15294

126112

(3024731) MCV [Entitic volume]

15731

131132

0.71

65.56

45.9

19.9

91.16

91.45

10.63

15505

128489

(3012501) Base excess in Blood by calculation

694

2690

2.07

65.55

4.6

4.2

2.81

2.60

mmol/l

1.11

504

1828

(3013290) Carbon dioxide [Partial pressure] in Blood

694

2692

2.07

65.42

4.7

4.2

4.97

5.02

kpa

0.86

681

2619

(3035941) MCH [Entitic mass]

15730

131112

0.71

65.29

45.8

19.9

30.05

30.45

110.12

15499

128479

(3025941) Bacteria identified in Stool by Culture

1260

5942

1.72

65.06

1.3

—

(40768806) Pleura Pathology biopsy report

337

944

2.85

64.69

1.4

1.5

—

(3007461) Platelets [#/volume] in Blood

15728

131069

0.71

64.69

46.0

20.0

250.63

244.00

e9/l

21.76

15339

126609

(3027315) Oxygen [Partial pressure] in Blood

695

2713

2.06

64.42

4.7

4.2

8.95

8.41

kpa

7.67

682

2639

(3023199) Leukocytes [#/volume] in Pleural fluid

395

1212

2.60

63.78

1.4

1.5

1745.46

3441.13

e6/l

1.15

288

893

(3037467) Urinalysis macro (dipstick) panel - Urine

11682

82430

1.30

63.13

5.1

4.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

15729

130988

0.71

62.90

46.6

20.1

37.30

40.39

228.11

14606

120353

(3010421) pH of Blood

760

3123

1.96

61.05

4.5

4.1

7.42

1.12

697

2817

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

998

4513

1.79

59.50

1.9

1.8

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

360

1094

2.63

59.27

1.4

1.5

73315.86

59492.87

e6/l

0.22

221

666

(3021440) Promyelocytes/100 leukocytes in Blood

1679

8737

1.57

58.49

3.3

3.7

0.14

0.07

3.73

786

2062

(3021589) Normoblasts [#/volume] in Blood

7510

50381

1.29

57.95

16.5

8.7

0.00

e9/l

0.36

6025

41243

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

177

356

3.95

56.93

3.0

2.3

—

(3012441) Differential panel - Pleural fluid

338

1016

2.65

56.87

1.4

1.5

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

136

224

4.82

55.97

1.2

1.6

36.42

50.32

g/l

0.20

105

170

(3045788) Cell count panel - Pleural fluid

314

918

2.73

55.73

1.4

1.5

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1599

8333

1.56

55.21

3.1

3.5

0.81

0.57

3.37

760

2096

(3051651) Icteric interference index of Serum or Plasma

232

577

3.20

54.64

5.4

4.1

—

(3020891) Body temperature

1105

5280

1.69

54.14

5.4

4.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

2396

13628

1.44

54.03

1.7

1.9

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

374

1222

2.44

53.08

2.4

2.8

2912.71

8349.28

u/ml

0.30

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

599

2392

2.01

52.15

1.5

1.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1557

8168

1.55

52.08

3.3

119.71

130.50

g/l

58.22

1519

7968

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

576

2281

2.02

51.32

1.5

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

412

1428

2.30

51.30

1.4

146.48

75.81

pmol/l

2.60

405

1394

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

7.38

51.13

6.3

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1102

5367

1.66

50.15

1.2

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

608

2502

1.95

48.60

1.4

1.3

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

7.52

48.15

1.9

3.0

55.58

58.19

0.16

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

456

1711

2.13

46.87

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

156

333

3.72

46.33

3.1

2.9

—

(3019225) pH of Specimen

2169

12445

1.42

46.11

4.6

3.7

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1230

6288

1.58

45.88

2.8

1.18

1.21

0.81

1221

6258

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

605

2540

1.91

45.58

1.5

—

(1616796) Gas panel - Central venous blood

621

2642

1.88

44.94

3.6

3.8

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1202

6147

1.58

44.75

2.8

0.68

0.65

1.88

1195

6124

(3025159) Blasts/100 leukocytes in Blood

1536

8319

1.50

43.99

3.3

3.8

0.14

0.07

0.39

640

1704

(3036782) Glucose [Moles/volume] in Pleural fluid

281

893

2.51

42.37

1.3

1.4

6.41

6.67

mmol/l

0.67

262

815

(3021960) Folate [Moles/volume] in Serum or Plasma

4724

30813

1.28

42.05

1.7

1.5

20.46

20.42

nmol/l

0.06

4186

25958

(3025468) Yersinia sp identified in Specimen by Organism specific culture

385

1412

2.18

41.94

1.5

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

389

1436

2.16

41.70

1.4

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1262

6630

1.54

41.64

3.5

3.3

24.62

25.31

mmol/l

8.61

1216

6425

(3005988) Vibrio sp identified in Specimen by Organism specific culture

385

1417

2.17

41.58

1.5

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

384

1413

2.17

41.49

1.5

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

397

1483

2.14

41.31

1.5

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

387

1434

2.15

41.10

1.5

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1325

7088

1.51

40.15

2.5

—

(3052851) Hemolysis interference index of Serum or Plasma

756

3531

1.72

40.12

4.3

3.3

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

271

870

2.48

40.03

1.3

687.72

396.79

u/l

0.51

254

808

(3043410) Blood group antigens tested for on Red Blood Cells

124

253

3.89

39.26

2.2

1.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

534

7439

0.55

38.76

1.7

1.9

—

(3045142) Bone marrow Pathology biopsy report

245

763

2.55

38.55

1.3

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1207

6404

1.52

37.97

3.1

2.6

0.50

0.30

e6/l

2.67

1195

6252

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3976

25666

1.28

37.78

3.7

4.0

412.45

581.48

ng/l

1.19

3350

21269

(21494755) Public health laboratory ask at order entry panel

498

7018

0.55

37.62

1.3

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

281

4766

0.46

37.57

1.4

1.5

—

(40761536) Microorganisms panel - Urine sediment

1633

9227

1.43

37.37

4.3

4.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

480

1994

1.92

37.35

3.5

3.4

59.26

58.54

0.53

480

1994

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

494

2080

1.90

36.92

1.5

—

(3000012) Reticulocyte production index

409

1648

1.98

34.79

1.9

1.8

—

(40767503) Oxygen content in Capillary blood by calculation

566

2567

1.76

33.32

2.6

2.5

14.85

16.55

13.07

266

1335

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

191

571

2.66

32.68

2.2

1.6

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

271

955

2.26

32.62

2.4

2.8

60.17

60.60

0.11

222

780

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

584

2699

1.73

32.20

4.3

2.8

1.70

1.71

mg/l

0.16

537

2397

(3003338) MCHC [Mass/volume]

11574

98003

0.83

32.11

41.4

18.0

329.12

332.35

g/l

233.01

11457

97130

(3019309) Folate [Moles/volume] in Red Blood Cells

4039

26568

1.25

31.95

1.8

1185.38

1159.32

nmol/l

0.90

3118

19858

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1132

6148

1.48

31.70

4.2

3.9

47.55

47.93

0.20

1120

6071

(3043409) Potassium [Moles/volume] in Arterial blood

806

4074

1.59

31.40

5.0

4.5

3.83

3.91

mmol/l

4.44

799

4042

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

563

2595

1.73

31.34

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

563

2596

1.73

31.30

1.3

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

6.42

31.08

1.7

3.0

24.90

14.26

0.92

(3049717) Cytology report of Urine Cyto stain

807

4103

1.58

30.67

2.9

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

381

1567

1.94

30.60

1.5

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

381

1567

1.94

30.60

1.5

1.4

—

(3028271) Lactate [Moles/volume] in Capillary blood

444

1922

1.84

30.51

1.9

1.82

1.74

mmol/l

0.83

438

1879

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

297

1117

2.12

30.49

1.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

7233

50698

1.20

30.37

3.9

47.35

76.21

ng/l

2.08

5834

37034

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

348

1406

1.97

29.44

1.5

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

252

901

2.22

29.35

1.6

1.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

5950

41044

1.21

29.32

2.9

3.1

1525.56

1575.88

ng/l

0.36

5214

35231

(3020564) Creatinine [Moles/volume] in Serum or Plasma

15462

126962

0.80

29.14

38.2

15.8

80.75

80.90

umol/l

0.19

15451

126910

(3005719) IgG [Mass/volume] in Serum or Plasma

1306

7463

1.41

27.80

2.4

2.3

10.67

10.83

g/l

0.56

1176

6766

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

141

394

2.84

27.47

2.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

275

1047

2.09

27.40

2.9

2.8

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

275

1047

2.09

27.40

2.6

3.0

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

119

304

3.10

27.08

1.4

2.45

2.62

0.07

100

249

(3035880) pH of Pleural fluid

174

547

2.52

27.02

1.2

1.3

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

131

355

2.93

26.96

1.3

54.86

63.84

1.81

110

281

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

216

756

2.27

26.52

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

308

1238

1.98

26.49

4.8

3.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

734

3780

1.55

26.38

2.4

2.9

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

6.33

26.33

1.7

1.2

2618.76

177.98

u/l

0.91

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

199

676

2.34

26.17

1.3

14.23

12.63

u/l

0.33

175

611

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

200

681

2.33

26.16

1.4

1.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

560

2709

1.65

26.10

3.6

2.9

8.01

7.94

kpa

0.31

545

2658

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1621

9694

1.35

26.06

4.2

2.4

64.43

62.26

ml/min/173m2

1.32

714

3767

(3006922) Hepatitis E virus Ab [Presence] in Serum

195

659

2.35

25.95

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

211

744

2.25

25.48

1.3

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

185

616

2.38

25.45

1.1

—

(1002224) Polysomnography panel

261

3974

0.51

25.43

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

15484

126780

0.82

25.12

21.1

9.4

28.85

26.01

u/l

27.35

15152

120947

(1175426) CD3 cells/100 lymphocytes in Blood

143

425

2.67

24.87

1.8

2.0

72.13

71.34

0.23

138

404

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

184

618

2.36

24.85

1.1

—

(3013512) EKG study

5496

38099

1.19

24.63

4.4

4.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

347

1492

1.85

24.45

1.1

1.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

322

1356

1.89

24.20

1.6

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1670

10140

1.33

24.16

2.4

1.6

64.22

66.82

g/l

28.27

1505

9007

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

23.73

1.1

0.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1148

12237

0.72

23.56

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1040

5889

1.42

23.27

1.8

1.5

1.39

1.19

g/l

1.39

941

5323

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

175

3.62

23.17

1.8

2.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

656

7700

0.66

23.06

2.3

2.4

29.55

26.50

au/ml

0.18

475

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

579

6972

0.64

23.03

1.2

1.3

56.04

54.41

au/ml

0.06

379

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

225

849

2.10

23.03

1.5

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

333

1441

1.84

23.02

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

369

1667

1.76

22.15

1.3

1.5

—

(21494814) CD8 cells/100 lymphocytes in Specimen

220

3.24

22.08

1.8

2.1

—

(3011412) CD3 cells [#/volume] in Blood

173

602

2.28

21.63

2.0

2.1

1.11

1.26

e9/l

0.37

159

546

(3000919) Neutrophils/100 leukocytes in Pleural fluid

103

277

2.94

21.58

1.3

1.4

27.59

21.52

1.15

246

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4598

41278

0.84

21.47

2.1

2.2

233.73

229.01

u/l

0.09

4322

38380

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

160

541

2.35

21.36

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

160

541

2.35

21.36

1.3

—

(3024928) Oxygen saturation in Venous blood

541

2728

1.58

21.36

2.6

3.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1780

11119

1.29

20.80

1.4

1.6

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

227

3.10

20.42

1.2

1.3

710.77

11.63

ug/l

1.55

105

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

358

1642

1.73

20.42

1.4

1.3

—

(3009343) pH of Capillary blood

1323

7958

1.33

20.33

3.6

3.5

7.42

0.22

189

963

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1338

8063

1.33

20.30

3.6

3.5

5.05

5.17

kpa

5.81

1256

7569

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

488

5928

0.64

20.21

1.2

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

394

1861

1.68

20.21

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

161

564

2.26

19.86

1.5

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1279

7682

1.34

19.84

3.5

2.00

1.84

mmol/l

0.65

908

5669

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

321

1442

1.77

19.70

1.4

1.3

—

(3021901) Oxygen saturation in Capillary blood

469

2333

1.60

19.64

2.9

2.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

160

562

2.26

19.62

1.5

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

379

1790

1.68

19.46

2.8

2.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

613

3255

1.50

19.19

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

607

3222

1.50

19.04

1.2

—

(3008037) Lactate [Moles/volume] in Venous blood

591

3127

1.51

18.83

3.7

3.2

1.74

1.63

mmol/l

1.38

581

3059

(3023383) Lactate [Moles/volume] in Pleural fluid

282

2.78

18.78

1.3

1.4

3.75

3.25

mmol/l

0.59

252

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

389

4887

0.62

18.74

1.6

1.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

167

610

2.17

18.66

2.9

1.8

—

(42529406) Shigella sp [Presence] in Stool by Culture

611

3267

1.49

18.51

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

327

1506

1.73

18.43

1.3

1.5

107.55

117.63

u/ml

0.97

324

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1913

12238

1.26

18.32

3.0

3.1

216.39

229.82

ng/l

0.65

1742

11215

(3015171) Extractable nuclear Ab [Units/volume] in Serum

353

4498

0.61

18.08

1.1

1.2

2.20

0.71

u/ml

0.61

418

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

226

937

1.91

17.94

1.5

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

344

4400

0.61

17.90

1.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

176

670

2.08

17.73

1.5

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1496

9328

1.29

17.65

2.5

1.8

409.84

367.20

nmol/l

10.50

1392

8412

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

213

875

1.93

17.39

1.5

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

213

875

1.93

17.39

1.5

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

213

875

1.93

17.39

1.5

1.3

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

7.62

17.37

1.6

1.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

7070

60718

0.87

17.30

2.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

243

3362

0.56

17.20

1.4

1.7

4.51

3.90

mg/l

0.43

205

2474

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

236

1009

1.86

17.09

1.6

1.4

—

(4200892) Spirometry reversibility

896

9453

0.74

17.03

1.4

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

246

1068

1.83

16.97

1.2

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

318

1489

1.70

16.93

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

352

1697

1.65

16.78

1.3

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

136

481

2.24

16.50

1.6

1.3

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

218

2.90

16.49

1.2

1.4

22.94

26.88

0.54

177

(3028717) Thiamine [Mass/volume] in Blood

100

3.95

16.49

1.2

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

136

482

2.24

16.42

1.6

1.3

—

(3008898) HLA-B27 [Presence]

200

2883

0.54

16.39

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

566

6403

0.69

16.39

1.2

1.3

209.08

244.49

u/ml

0.65

508

5918

(3024980) IgG subclass 4 [Mass/volume] in Serum

361

1763

1.63

16.37

1.5

1.6

0.88

0.86

g/l

0.07

258

1319

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1221

12270

0.77

16.34

1.4

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

130

453

2.27

16.33

1.7

1.4

3.99

3.87

mg/l

0.12

122

427

(3022475) Manganese [Moles/volume] in Blood

6.24

16.31

1.3

1.2

—

(3038515) Glucose [Moles/volume] in Venous blood

553

2979

1.48

16.19

3.9

3.3

7.86

7.80

mmol/l

0.20

545

2918

(3019977) pH of Arterial blood

182

729

1.98

16.02

3.3

2.4

7.41

7.42

0.16

244

(4094501) Cardiovascular stress test using bicycle ergometer

286

3722

0.60

16.02

1.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

7555

54969

1.14

16.00

2.2

2.0

88.24

94.98

pmol/l

29.30

4506

27984

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

4.37

15.72

2.3

4.5

1.57

1.32

mg/l

0.24

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

245

1089

1.79

15.69

1.4

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

245

1090

1.78

15.64

1.4

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

643

3594

1.43

15.52

5.0

4.2

—

(40765096) Chromosome analysis panel by Banding

135

3.40

15.47

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

128

456

2.22

15.30

2.4

2.6

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

5.57

15.14

1.1

1.0

2.64

1.53

ug/l

0.64

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

108

359

2.38

15.13

1.7

1.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

15432

117894

1.17

15.10

31.0

13.6

37.93

24.08

mg/l

307.65

14519

92622

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1398

13674

0.79

14.93

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

106

353

2.38

14.80

1.7

1.3

—

(3003181) Sodium [Moles/volume] in Urine

441

2312

1.52

14.76

1.4

1.3

58.37

63.82

mmol/l

1.91

314

1845

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

106

354

2.37

14.71

1.7

1.3

—

(3042631) Mycobacterium sp identified in Specimen

310

1517

1.62

14.02

2.3

2.9

—

(3017569) Oxygen content in Arterial blood

154

611

2.00

14.00

3.1

2.1

—

(3024471) HLA-A [Type]

319

2.41

13.95

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

3.67

13.79

1.2

1.0

—

(3024932) HLA-DR beta [Type]

312

2.41

13.71

1.1

1.0

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

581

3264

1.42

13.68

3.1

24.20

24.91

mmol/l

3.03

567

3205

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

246

1142

1.71

13.62

1.1

75.00

57.17

u/l

1.47

226

1005

(3052592) Norovirus Ag [Presence] in Stool

236

2.61

13.34

1.4

1.3

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

113

3.43

13.31

1.3

1.4

75.67

63.67

1.79

(3001019) Free T4 and TSH panel - Serum or Plasma

292

3615

0.63

13.28

1.5

1.7

—

(3037522) Nuclear Ab [Titer] in Serum

1607

15283

0.81

13.17

1.3

485.11

558.18

titre

0.85

352

3418

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

122

3.31

13.11

1.3

57.06

308.10

u/l

0.45

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

143

3.10

12.98

1.4

10.66

9.26

0.14

(4034850) Laboratory test

383

4458

0.67

12.95

14.5

10.5

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

254

3224

0.62

12.90

1.6

1.7

45.38

43.73

nmol/l

0.32

237

3102

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

337

2.30

12.81

5.5

1.1

36.50

280.69

u/ml

3.63

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

207

933

1.76

12.75

1.4

1.2

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

3.81

12.63

1.2

1.4

1.44

0.93

ml/s/173m2

1.60

(3039443) Prostate specific Ag panel - Serum or Plasma

175

2426

0.57

12.60

1.5

1.6

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

1090

0.36

12.57

1.0

34.28

43.45

ng/l

1.44

731

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

155

2220

0.55

12.54

1.1

1.2

62.50

49.79

u/ml

—

229

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

313

1579

1.57

12.53

1.3

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

331

2.30

12.48

2.8

2.6

37.69

43.28

2.32

170

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

1086

0.36

12.48

1.0

692.71

714.37

ng/l

0.16

712

(40761511) CBC panel - Blood by Automated count

15079

122363

0.87

12.42

29.1

13.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

1082

0.36

12.38

1.0

253.52

337.25

ng/l

2.59

738

(3012516) Albumin [Mass/volume] in Urine

4879

42262

0.88

12.32

3.2

3.3

404.00

315.55

mg/l

0.72

3280

26967

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

247

2.50

12.21

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

294

3554

0.65

12.02

1.7

1.6

14740.54

14623.01

e6/l

0.02

209

2593

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

199

2.66

11.92

2.0

1.4

23.58

38.01

u/l

0.72

176

(40761539) Cells [Type] in Urine sediment by Light microscopy

260

2.43

11.87

1.2

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

147

2.96

11.85

1.3

1.28

0.98

mmol/l

0.21

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

296

1496

1.57

11.79

1.3

1.2

326.75

289.95

u/ml

1.08

194

977

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

458

2539

1.43

11.67

1.2

1.3

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

16.68

11.64

1.1

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.71

11.50

1.6

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

259

3184

0.64

11.47

1.2

1.3

38.78

43.22

u/ml

—

186

(3006184) Hemoglobin [Mass/volume] in Capillary blood

513

2926

1.39

11.15

2.3

2.2

119.33

131.19

g/l

20.13

379

2120

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

289

2.30

11.03

2.0

1.8

46122.30

44256.43

u/ml

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

159

693

1.82

11.02

1.2

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

112

434

2.04

10.97

30.9

27.0

124.47

114.05

ug/l

0.99

354

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1786

16508

0.84

10.71

4.2

4.9

33.05

32.68

0.70

1166

11135

(3000494) Fungus identified in Specimen by Culture

2017

13666

1.18

10.69

1.6

1.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

122

1781

0.54

10.61

3.7

4.6

322.87

354.16

umol/l

1.43

1498

(3020682) Albumin/Creatinine [Ratio] in Urine

5209

44636

0.89

10.60

3.8

11.55

8.68

mg/mmol

2.72

3384

28242

(3048929) Epstein Barr virus Ab [Presence] in Serum

385

2108

1.45

10.53

1.3

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

351

3988

0.69

10.51

1.4

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

160

713

1.78

10.34

2.4

2.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

152

672

1.79

10.10

1.5

6.28

7.55

u/l

0.44

114

550

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

313

3603

0.68

10.08

1.5

1.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4009

28699

1.13

9.87

1.8

1.7

18981649.25

31505987.00

pmol/l

0.82

3298

23307

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.19

9.84

1.1

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

5034

43056

0.90

9.71

3.2

7.34

7.46

mmol/l

1.18

4091

36034

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3556

25301

1.13

9.63

1.8

1.7

2.31

1.22

mg/l

23.98

2937

19475

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

247

2948

0.66

9.59

1.1

1.3

6.32

6.19

u/ml

0.01

491

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

309

2.15

9.48

1.5

1.3

2069639.38

1652082.14

iu/ml

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

155

2050

0.59

9.45

1.4

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

4181

30083

1.12

9.39

4.3

3.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

15634

126120

0.88

9.35

36.2

16.6

3.96

3.99

mmol/l

43.63

15347

122300

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

245

2913

0.66

9.34

1.1

1.3

6.09

6.37

u/ml

0.03

323

(3022313) Gas panel - Capillary blood

914

5802

1.26

9.34

3.7

3.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

177

837

1.68

9.32

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

5.27

9.28

3.9

1.7

—

(3004451) EKG impression Narrative

144

645

1.77

9.21

1.2

1.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

4.20

9.03

1.1

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

446

2581

1.37

8.97

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

3.20

8.90

1.6

1.1

76.19

106.48

ng/l

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

176

847

1.65

8.70

1.8

1.7

1640.20

2586.32

u/l

0.24

315

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

114

484

1.86

8.70

1.3

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

114

484

1.86

8.70

1.3

1.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

230

1181

1.54

8.68

1.3

1.33

1.43

nmol/l

0.59

206

1069

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

146

669

1.73

8.66

1.2

168.63

87.74

u/l

2.01

128

577

(3048689) Calprotectin [Mass/mass] in Stool

1826

12482

1.17

8.65

1.9

2.2

246.68

145.24

ug/g

14.29

1469

9716

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

142

646

1.74

8.64

1.2

42.80

22.30

u/l

2.42

122

546

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

358

3905

0.72

8.54

1.4

—

(3016244) Insulin [Units/volume] in Serum or Plasma

104

433

1.90

8.43

2.1

3.1

13.93

26.57

mu/l

4.99

406

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

4.79

8.41

1.1

1.0

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

117

507

1.83

8.39

2.4

5.5

56.61

944.47

mg/l

0.82

350

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

264

3025

0.68

8.37

1.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

2755

19452

1.14

8.31

1.5

1.3

2.79

2.66

g/l

2.04

1634

10992

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

242

2808

0.68

8.21

1.3

572.97

554.41

mg/l

0.19

237

2653

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

316

1754

1.43

8.15

1.1

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

139

2.62

8.05

1.4

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

193

2330

0.65

8.00

1.7

1.9

192.03

198.17

pmol/l

0.43

181

2184

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

419

2449

1.36

7.97

1.5

1.7

—

(3026250) Tacrolimus [Mass/volume] in Blood

414

1.89

7.95

35.6

35.7

6.93

7.34

ug/l

1.48

379

(3019550) Sodium [Moles/volume] in Serum or Plasma

15623

125801

0.89

7.88

36.1

16.5

138.84

139.77

mmol/l

311.38

15355

122191

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

140

657

1.69

7.68

1.7

1.9

2.44

2.47

u/field

0.02

108

436

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

+∞

7.59

1.0

0.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

206

1067

1.53

7.55

1.9

2.2

2.47

2.19

u/field

0.31

387

(3042733) HLA Ab [Presence] in Serum

372

1.91

7.51

2.2

5.3

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

192

981

1.55

7.48

1.2

30.00

121.25

titre

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

192

981

1.55

7.48

1.2

98.75

166.53

titre

1.90

173

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

157

1951

0.63

7.47

1.7

—

(3040151) Glucose [Moles/volume] in Capillary blood

270

1481

1.44

7.46

7.8

13.3

7.45

7.69

mmol/l

0.46

234

1212

(3019150) Specific gravity of Urine by Refractometry

3140

27217

0.89

7.37

4.3

1.02

kg/l

0.35

540

4132

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1925

17202

0.87

7.37

12.2

7.3

—

(3000060) B lymphocytes [#/volume] in Blood

132

2.57

7.33

1.8

1962.73

158.78

e6/l

0.78

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1361

0.57

7.32

1.1

2.62

1.45

u/ml

0.33

693

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

899

0.47

7.22

1.2

1.4

150.65

180.05

pmol/l

1.10

899

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

611

6041

0.79

7.20

1.1

1.2

139.48

132.94

iu/ml

0.14

195

2287

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

773

4967

1.24

7.16

3.9

3.8

24.74

24.91

mmol/l

0.65

694

4523

(3027923) C peptide [Moles/volume] in Serum or Plasma

151

737

1.62

7.16

1.3

1.05

1.25

nmol/l

1.89

119

556

(3017315) Amylase [Enzymatic activity/volume] in Urine

138

659

1.66

7.13

1.3

1.2

307.91

375.50

u/l

0.32

128

609

(3000330) Specific gravity of Urine by Test strip

1018

6732

1.20

7.10

5.0

3.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

212

2447

0.68

7.07

1.4

12.70

25.82

e6/l

1.26

164

1924

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1174

0.54

7.05

1.0

1.1

1.66

1.18

u/ml

0.30

463

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

213

2450

0.68

6.97

1.5

1.4

269.75

1651.95

e6/l

4.88

174

2033

(3004716) Salmonella sp identified in Stool by Organism specific culture

708

4521

1.24

6.96

1.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

7823

58731

1.09

6.93

5.5

5.1

0.00

estimate

0.51

1744

10082

(3009261) Glucose [Presence] in Urine by Test strip

7914

59443

1.09

6.93

4.1

3.8

0.00

estimate

0.22

1712

9766

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

440

2654

1.32

6.83

1.4

1.5

0.77

0.81

nmol/l

0.62

381

2183

(3006245) CD3-CD19+ cells/100 cells in Blood

201

2.20

6.83

2.0

1.9

13.55

9.58

0.91

185

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

123

1578

0.61

6.77

1.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

1208

0.56

6.73

1.0

1.1

6.84

3.40

u/ml

0.66

556

(3021788) Differential panel - Synovial fluid

230

2583

0.70

6.62

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

733

4728

1.23

6.59

2.1

2.3

469.40

646.55

ug/l

0.66

705

4441

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

217

2456

0.69

6.53

1.2

3.90

3.89

mmol/l

0.03

206

2312

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

241

2667

0.71

6.39

1.3

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

113

528

1.69

6.38

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

146

732

1.58

6.26

1.1

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

3.85

6.19

1.1

1.0

1.08

0.90

u/field

0.77

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

149

2.33

6.17

2.0

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

207

2.10

6.02

1.3

1.2

1.36

1.49

mmol/l

0.29

105

(1001926) Buprenorphine [Presence] in Urine by Screen method

1266

0.60

5.97

1.5

1.9

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

222

2456

0.71

5.91

1.1

1.2

3.78

6.22

u/ml

0.53

199

(3037756) Immunofixation for Serum or Plasma

396

2407

1.30

5.88

1.5

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

457

1.71

5.88

2.0

525.28

511.52

e6/l

0.05

394

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

232

2545

0.72

5.87

1.1

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

13932

112421

0.92

5.87

31.1

12.6

77.90

76.04

ml/min/173m2

21.58

12435

90515

(3028300) Cannabinoids [Presence] in Urine

135

1635

0.65

5.81

1.4

1.9

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

155

804

1.53

5.76

1.0

1.1

—

(3027008) Opiates [Presence] in Urine

135

1631

0.65

5.75

1.4

1.7

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

3.28

5.75

1.3

1.2

1.92

1.45

pmol/l

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

437

1.72

5.72

2.1

2.0

0.24

0.22

e9/l

0.27

388

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

143

730

1.55

5.71

1.4

1.5

13.05

13.80

umol/l

0.52

134

682

(3029937) Albumin [Presence] in Urine by Test strip

4394

32402

1.09

5.70

4.3

4.2

0.00

estimate

0.25

1558

9730

(3000764) Benzodiazepines [Presence] in Urine

135

1626

0.65

5.68

1.4

1.9

—

(3044941) Cell count panel - Synovial fluid

198

2217

0.70

5.67

1.4

—

(3016879) Cocaine [Presence] in Urine

125

1517

0.65

5.47

1.4

1.9

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

157

827

1.50

5.45

1.1

300.30

285.68

mg/l

1.32

141

742

(44813793) Dust mix specific IgE antibody measurement

745

0.51

5.34

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

232

1324

1.39

5.28

2.4

2.1

0.98

1.33

g/24h

1.67

135

619

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

125

2.34

5.27

1.1

—

(3035350) Ketones [Presence] in Urine by Test strip

7804

59006

1.07

5.26

4.1

3.8

0.00

estimate

0.33

1855

10979

(3027944) Amphetamines [Presence] in Urine

135

1591

0.67

5.14

1.4

1.8

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

886

0.57

4.89

1.0

4.80

2.96

u/ml

0.46

417

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

105

2.41

4.87

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1123

0.62

4.87

1.1

—

(3017732) Neutrophils [#/volume] in Blood

1125

7754

1.15

4.85

4.0

2.9

5.02

5.14

e9/l

0.11

896

5878

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.70

4.79

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1354

9472

1.14

4.72

3.6

3.9

94.17

95.32

ng/l

0.17

1179

7977

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

137

2.19

4.70

1.4

1.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

188

1058

1.41

4.70

1.1

—

(44786800) Granulocytes/100 leukocytes in Body fluid

122

2.27

4.68

1.4

1.3

37.14

28.68

0.59

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

669

0.52

4.65

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

101

1234

0.64

4.63

1.0

1.1

1.78

1.57

iu/ml

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.71

4.62

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

338

3387

0.78

4.61

1.5

1.6

5.35

3.30

iu/ml

0.21

766

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1019

0.61

4.60

1.0

1.75

1.18

u/ml

0.34

501

(3008295) Osmolality of Serum or Plasma

197

1123

1.39

4.58

1.2

1.4

275.25

276.67

mosm/kgh2o

0.36

159

837

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

131

1512

0.68

4.54

1.1

1.0

—

(3014271) Vancomycin [Susceptibility]

148

803

1.46

4.52

2.8

3.1

—

(21494434) Karyotype in Bone marrow

151

824

1.45

4.48

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

207

2207

0.74

4.48

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

238

2484

0.75

4.45

1.6

1.8

5.64

8.00

iu/l

0.27

846

(3047007) Chlamydophila sp Ab [Presence] in Serum

113

1332

0.67

4.38

1.2

1.3

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

725

0.55

4.33

1.0

0.75

0.47

u/ml

0.16

226

(3026493) Urate [Moles/volume] in Serum or Plasma

4002

33542

0.93

4.32

3.0

2.5

3945.40

5383.18

umol/l

1.40

3447

28735

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

244

2518

0.76

4.23

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

165

1804

0.72

4.22

1.6

1.5

60.44

59.34

0.12

101

1164

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

415

1.62

4.21

2.6

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

415

1.62

4.21

2.6

2.4

—

(3011288) Drugs identified in Urine by Screen method

1044

0.63

4.21

1.7

2.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

477

1.57

4.20

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

106

547

1.53

4.16

1.1

95.06

84.21

u/l

0.56

101

480

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

1086

0.65

4.11

1.1

—

31.54

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

122

1398

0.69

4.11

1.0

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

117

1347

0.68

4.05

1.5

28.63

27.69

0.10

855

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

294

1.72

4.00

1.3

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

496

1.55

3.98

1.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

117

623

1.49

3.98

2.4

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

4.74

3.98

1.2

1.1

1.00

0.73

u/field

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

11.05

3.97

1.1

1.0

50.86

17.60

umol/l

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

491

1.55

3.94

1.6

1.5

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

105

548

1.51

3.94

1.1

38.07

23.85

u/l

1.32

476

(3044889) 12 lead EKG panel

11250

86560

1.06

3.94

4.5

4.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

452

2940

1.22

3.92

2.3

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

1022

0.65

3.85

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

116

1324

0.69

3.85

1.2

7.87

7.66

mmol/l

0.31

106

1112

(3037692) Legionella sp identified in Specimen by Organism specific culture

340

1.65

3.83

1.4

1.5

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

776

0.60

3.80

1.2

1.3

0.17

1.35

u/ml

6.05

467

(3008536) Aspergillus sp Ab [Presence] in Serum

178

1.91

3.77

1.9

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

125

1399

0.70

3.73

1.4

1.3

88816.79

148057.93

e6/l

0.63

971

(3032057) Clostridioides difficile [Presence] in Stool

289

1.70

3.71

1.7

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

907

0.63

3.71

1.0

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.63

3.70

1.7

2.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

267

1651

1.28

3.65

1.3

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

439

1.55

3.60

1.6

1.7

6.15

9.85

nmol/l

0.28

361

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

385

0.45

3.59

1.8

2.6

147.06

141.71

nmol/l

0.08

335

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

127

1403

0.71

3.54

1.1

10.00

11.62

au/ml

—

(3002385) Erythrocyte distribution width [Ratio]

12469

100401

0.94

3.53

39.1

15.7

15.70

15.36

6.58

12330

98256

(3004616) Nuclear Ab [Presence] in Serum

142

1540

0.73

3.53

1.2

1.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

133

2.02

3.51

1.8

1.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

820

0.63

3.39

1.0

4.44

3.06

u/ml

0.37

322

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

349

3352

0.82

3.35

1.4

1.6

0.24

g/l

0.04

326

3168

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

1045

0.68

3.33

1.1

—

57.79

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

136

1.97

3.32

1.2

57.76

112.73

ug/l

3.21

(3022689) Creatine [Moles/volume] in Urine

393

0.48

3.29

1.4

1.5

—

(40758292) HTLV I+II Ab panel - Serum

2.40

3.27

1.5

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

675

0.61

3.24

1.2

1.1

54.40

43.16

mg/l

0.74

575

(3013166) Neutrophils/100 leukocytes in Synovial fluid

471

0.54

3.17

1.3

58.39

58.59

0.01

407

(3024263) Appearance of Synovial fluid

749

0.63

3.17

1.2

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

612

0.59

3.17

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

588

3998

1.17

3.17

2.5

1.5

37.66

34.55

mg/l

0.79

487

3221

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

460

0.53

3.16

1.1

87.40

843.44

ng/l

—

109

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

196

1.77

3.13

1.5

1.1

2.34

2.52

ug/l

0.08

132

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

572

3886

1.17

3.12

2.5

1.5

1.68

2.10

ratio

0.43

320

(3029634) Reagin Ab [Titer] in Serum by VDRL

118

1286

0.72

3.08

1.8

2.1

1.80

5.07

titre

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

588

4010

1.16

3.06

2.5

1.5

65.19

46.88

mg/l

1.02

486

3238

(3001964) Herpes simplex virus Ag [Presence] in Specimen

257

1.66

3.06

1.4

1.6

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

2.18

3.03

1.0

1.1

7.29

15.21

iu/ml

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

883

0.67

3.02

1.0

1.1

—

35.88

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

229

1427

1.27

3.02

1.4

1.2

—

nmol/l

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

622

0.61

3.00

1.1

1.4

1.54

g/l

0.07

622

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

114

2.01

3.00

1.1

22.87

18.54

u/l

0.39

(3014891) Appearance of Pleural fluid

170

1.81

2.99

1.5

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

237

1485

1.26

2.99

1.3

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

362

3421

0.83

2.98

1.4

1.5

1.16

1.18

g/l

0.84

341

3231

(3008116) Ketones [Moles/volume] in Urine by Test strip

253

1.66

2.98

1.2

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

775

0.65

2.97

1.6

2.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.45

2.94

1.2

1.4

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

268

0.41

2.93

3.6

3.0

7.73

6.86

mg/l

—

215

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

715

0.64

2.93

1.1

2.58

6.12

nmol/l

0.79

147

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

255

1618

1.25

2.90

1.4

1.2

0.68

2.25

nmol/l

0.94

240

1548

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

817

0.67

2.88

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

816

0.67

2.87

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

815

0.67

2.85

1.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

812

0.67

2.81

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

812

0.67

2.81

1.1

1.2

—

(40763590) HLA-DQ beta [Type]

5.53

2.80

1.0

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

1044

0.71

2.79

1.8

2.0

3.70

3.62

ug/l

0.04

965

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.53

2.78

1.0

1.1

36.18

36.14

0.01

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.53

2.78

1.0

1.1

8.50

9.02

0.23

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.53

2.78

1.0

1.1

21.31

21.98

0.21

(40759836) Histone Ab [Presence] in Serum by Immunoblot

809

0.67

2.76

1.1

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

559

0.61

2.75

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

489

0.58

2.74

1.1

—

(3002619) Bacteria identified in Specimen by Culture

229

1.66

2.73

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

445

1.46

2.67

1.1

1.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

181

1116

1.28

2.65

1.3

1.4

0.44

0.43

g/l

0.10

113

779

(3028192) IgG subclass 2 [Mass/volume] in Serum

181

1116

1.28

2.65

1.3

1.4

3.00

3.03

g/l

0.06

112

774

(40760409) HLA-A [Type] by High resolution

5.02

2.63

1.0

1.1

—

(40760410) HLA-B [Type] by High resolution

5.02

2.63

1.0

1.1

—

(46236302) HLA-C [Type] by High resolution typing

5.02

2.63

1.0

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

181

1118

1.28

2.62

1.3

1.4

6.70

6.94

g/l

0.33

113

777

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1625

11870

1.09

2.61

1.7

1.59

1.54

1.75

1380

10163

(3004588) Protein electrophoresis panel - Serum or Plasma

1225

8835

1.10

2.61

2.1

1.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

253

1626

1.23

2.60

1.4

1.2

0.18

0.27

nmol/l

0.83

123

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

706

4940

1.13

2.60

2.1

1.4

3.74

3.77

g/l

0.22

627

4346

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

637

0.64

2.60

1.1

396.96

292.82

mg/l

1.02

568

(3025577) Chromium [Mass/volume] in Blood

1011

0.72

2.59

2.0

2.1

2.26

2.31

ug/l

0.05

842

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.29

2.58

4.9

1.4

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

3.74

2.57

4.0

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

5.92

2.57

1.2

1.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

189

1178

1.27

2.55

1.9

1.3

—

(4062490) Immunoglobulin typing, IgG

180

1116

1.28

2.54

1.3

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

594

4117

1.14

2.54

1.6

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

707

4957

1.13

2.53

2.1

1.4

7.58

7.50

g/l

0.62

627

4362

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

706

4952

1.13

2.51

2.1

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

101

578

1.38

2.48

1.3

—

(3013862) HLA-DP [Type]

4.60

2.47

1.0

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

609

0.65

2.45

3.8

5.0

324.63

484.77

u/ml

—

110

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

142

858

1.31

2.45

1.2

10.46

9.15

mmol/l

2.29

128

810

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

293

1.54

2.43

1.1

—

(3045716) Anion gap in Serum or Plasma

109

636

1.35

2.39

2.3

9.79

9.74

mmol/l

0.05

102

624

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

193

1217

1.25

2.39

3.9

3.7

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

793

0.70

2.38

2.1

1.7

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

338

0.54

2.36

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

338

0.54

2.36

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

338

0.54

2.36

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

338

0.54

2.36

1.0

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.57

2.35

1.1

1.0

250.08

292.21

nmol/l

0.31

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

208

0.42

2.31

1.3

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

540

1.38

2.29

2.3

1.6

42.21

9.60

umol/l

2.22

385

(3036670) Protein [Mass/volume] in Synovial fluid

463

0.61

2.27

1.1

1.3

41.39

39.85

g/l

0.24

249

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.50

2.25

1.7

1.4

0.19

1.86

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.50

2.25

1.7

1.4

0.99

2.39

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

2.50

2.25

1.7

1.4

3.10

1.66

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.50

2.25

1.7

1.4

1.91

3.80

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

2.50

2.25

1.7

1.4

0.29

0.66

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

2.50

2.25

1.7

1.4

0.50

2.37

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.50

2.25

1.7

1.4

0.10

0.87

mg/l

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

481

0.62

2.24

1.1

1.97

1.04

u/l

0.59

228

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.32

2.24

1.1

1.5

1.00

1.03

u/field

—

(3016038) Potassium [Moles/volume] in Urine

144

885

1.29

2.22

1.3

1.2

35.24

34.15

mmol/l

0.22

130

730

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

657

4632

1.12

2.19

2.1

1.4

3.07

2.94

g/l

2.43

578

4039

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

103

1079

0.75

2.18

1.4

1.8

2586.67

2363.48

titre

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

398

0.59

2.16

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

484

0.64

2.13

1.6

1.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

708

0.70

2.10

1.8

1.4

8.19

5.90

u/l

0.38

596

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1745

12908

1.07

2.08

2.2

2.4

4.98

7.90

ug/l

12.34

1467

11167

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

2.49

2.07

1.3

3.63

2.34

0.27

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

4796

39188

0.95

2.07

4.1

3.7

21.66

24.25

26.52

2362

18514

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.39

2.06

1.7

1.4

0.77

1.29

mg/l

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

140

0.39

2.06

1.7

2.0

20.30

18.21

umol/l

—

140

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

584

0.67

2.06

1.0

1.1

8.33

11.15

iu/ml

—

113

(3047189) Immunofixation for 24 hour Urine

397

1.41

2.05

1.5

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

110

1129

0.77

2.03

1.3

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

287

1.49

2.03

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

103

1.84

2.02

1.7

1.6

1.24

1.10

mmol/l

0.09

(3006653) Thiamine [Moles/volume] in Blood

587

1.33

2.01

1.1

1.2

130.72

140.14

nmol/l

1.06

587

(40762814) Titanium [Mass/volume] in Blood

310

0.56

2.01

2.2

2.3

3.27

3.28

ug/l

—

113

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

552

0.67

2.00

1.1

1.07

ratio

0.00

185

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

6364

48824

1.04

1.99

2.3

2.2

74.73

78.76

nmol/l

22.91

5737

42627

(3012565) Volume of 24 hour Urine

555

1.34

1.97

1.8

1.9

1651.52

1922.67

2.28

477

(3004347) Hepatitis D virus Ab [Presence] in Serum

3.45

1.96

1.0

—

(3023410) Appearance of Cerebral spinal fluid

100

1033

0.76

1.96

1.5

—

(3006270) Folate [Moles/volume] in Blood

181

1164

1.23

1.95

1.2

345.91

336.24

nmol/l

0.23

143

934

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

215

2036

0.83

1.94

1.3

1.2

55.53

23.12

u/l

1.39

185

1733

(3051101) Glucose [Moles/volume] in Cord blood

326

0.58

1.93

6.3

6.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

111

674

1.30

1.92

2.3

2.2

45.74

145.16

ug/min

1.89

165

(3034891) Synovial lining cells/100 cells in Synovial fluid

668

0.71

1.92

1.5

1.4

2.65

4.28

0.71

154

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

124

0.38

1.92

1.0

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.15

1.92

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

113

1143

0.78

1.89

1.5

1.6

26.45

25.65

u/ml

0.06

269

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

956

0.76

1.89

1.2

1.3

80.00

452.42

titre

—

(3014051) Protein [Presence] in Urine by Test strip

462

3222

1.13

1.89

2.7

2.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

275

1846

1.18

1.89

1.6

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

203

1.56

1.87

1.2

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

142

1.67

1.85

2.0

2.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

652

4650

1.11

1.83

2.0

1.4

10.29

10.21

g/l

0.18

567

4039

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.88

1.81

1.5

1.3

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

102

1037

0.78

1.80

1.1

1.2

36.00

48.69

u/ml

—

(3020874) Milk IgE Ab [Units/volume] in Serum

406

0.64

1.79

1.1

1.0

0.96

0.89

u/ml

—

137

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

552

1.32

1.77

1.1

1.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

107

656

1.29

1.76

1.3

34.02

33.63

u/l

0.04

472

(3015076) Soybean IgE Ab [Units/volume] in Serum

307

0.59

1.75

1.1

1.0

0.35

1.21

u/ml

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

170

1.58

1.72

2.5

2.9

0.79

0.55

u/field

0.63

170

(43055442) Apixaban [Mass/volume] in Serum or Plasma

202

1.52

1.70

1.5

1.6

93.77

122.67

ug/l

1.46

168

(3009015) Lactate [Moles/volume] in Synovial fluid

171

0.46

1.69

1.2

1.3

3.42

6.62

mmol/l

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

343

3086

0.87

1.67

1.7

1.9

12.18

11.38

mg/l

0.52

313

2848

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

417

0.66

1.65

1.1

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

147

1.61

1.65

2.0

2.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

307

2108

1.15

1.63

3.1

3.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

518

0.70

1.62

1.3

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

434

0.67

1.62

1.1

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

443

0.68

1.62

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.39

1.61

1.3

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3336

27330

0.96

1.60

2.9

2.7

0.80

0.70

ug/l

4.51

2310

18393

(3028433) Virus identified in Specimen by Culture

343

1.38

1.60

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

606

0.73

1.57

1.4

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

176

0.49

1.56

1.5

2.7

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.15

1.56

1.0

1.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

536

1.30

1.55

5.0

6.5

24.85

25.26

mmol/l

0.28

487

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

113

0.42

1.54

1.0

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

266

1.43

1.53

1.1

1.3

2.33

2.92

umol/l

0.79

244

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

163

1.55

1.52

1.1

1.3

80.75

124.60

ng/l

0.73

114

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

100

0.39

1.52

1.2

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

127

812

1.24

1.52

2.8

2.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

148

0.48

1.52

1.0

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.05

1.51

1.5

1.4

—

(3000492) Spirometry study

1275

10700

0.94

1.49

1.4

1.5

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

378

0.67

1.48

1.1

1.0

0.85

0.64

u/ml

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

262

0.60

1.46

1.4

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

405

0.68

1.46

1.0

1.1

1445.03

1621.19

miu/ml

0.43

405

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

202

0.55

1.46

1.1

1.0

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

290

0.63

1.44

1.4

1.9

9.82

9.10

mg/l

0.30

231

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

570

4098

1.10

1.44

2.2

1.5

0.85

0.39

g/l

2.83

482

3455

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

347

0.66

1.44

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

510

3648

1.11

1.43

2.2

1.5

0.08

0.01

g/l

0.59

454

3289

(3007916) DNA double strand Ab [Titer] in Serum

159

0.50

1.42

1.0

1.3

—

97.45

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.94

1.42

1.0

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.06

1.41

1.2

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.74

1.41

1.3

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

297

0.64

1.40

1.6

159.00

122.35

ng/l

0.47

297

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

297

0.64

1.40

1.5

—

(3048879) Bone marrow aspiration report

285

1.39

1.6

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

440

3131

1.11

1.37

3.1

0.84

0.82

nmol/l

0.42

345

2435

(3000034) Microalbumin [Mass/volume] in Urine

192

1293

1.17

1.36

3.1

3.0

41.47

47.25

mg/l

0.15

140

923

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

197

0.56

1.35

1.0

1.1

9.08

9.86

u/ml

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

182

1683

0.85

1.35

1.1

1.3

174.85

207.96

miu/ml

0.49

669

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

227

2063

0.87

1.34

1.2

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

452

0.72

1.33

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

404

0.70

1.30

1.5

1.4

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.87

1.30

2.2

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

522

0.74

1.29

1.2

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

479

3437

1.10

1.29

1.6

1.7

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

403

0.70

1.29

1.1

97.41

99.79

0.16

312

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

172

1156

1.18

1.27

1.0

1.1

5.60

3.79

u/ml

0.43

437

(36303858) Crystals [Presence] in Urine

2.82

1.26

1.0

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

568

4877

0.92

1.25

1.7

1.8

38.99

38.82

u/l

0.07

503

4206

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

473

3399

1.10

1.25

2.2

1.5

0.01

0.00

g/l

0.91

417

3050

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

258

1.38

1.24

1.0

1.1

78.52

86.69

0.60

132

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

619

1.24

1.23

3.8

4.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.87

1.20

1.4

2.2

—

(3009871) Measles virus Ab [Titer] in Serum

314

0.68

1.20

1.7

1.6

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

919

0.81

1.19

1.2

1.3

122.86

62.63

titre

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

266

0.65

1.19

1.1

—

(3015736) pH of Urine

6141

47466

1.03

1.18

3.7

3.6

5.74

5.81

0.73

258

2504

(3018834) Bilirubin.total [Presence] in Urine by Test strip

2.63

1.18

2.2

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.63

1.18

4.0

1.9

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

188

0.59

1.17

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

265

0.65

1.17

1.0

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

248

1.37

1.16

2.4

2.1

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

0.00

1.16

0.0

1.0

—

3.50

—

(3012403) Metanephrines [Moles/time] in 24 hour Urine

0.00

1.16

0.0

1.1

—

25.04

—

(3036071) Salmonella sp Ab [Titer] in Serum

301

0.68

1.14

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

355

0.71

1.12

1.5

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

110

0.50

1.11

1.1

—

(3041184) Isoniazid [Presence] in Urine

2.47

1.10

1.8

2.9

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.47

1.10

4.0

2.1

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

1.80

1.10

1.7

1.2

0.06

0.07

g/l

—

(3001729) Color of Synovial fluid

117

0.54

1.05

1.1

1.6

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

118

0.53

1.05

1.0

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

531

3875

1.08

1.04

2.2

1.4

36.52

37.50

g/l

2.92

449

3275

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.46

1.02

1.4

1.8

0.78

1.62

mg/l

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

238

1672

1.12

1.01

2.0

2.2

36.22

26.64

mg/l

1.00

448

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.87

0.99

1.2

1.1

—

(3016330) Potassium [Moles/time] in 24 hour Urine

169

0.61

0.99

1.1

1.2

—

90.29

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

328

0.72

0.99

1.4

1.6

0.36

ug/l

0.01

200

(40757373) Influenza virus identified in Isolate

242

1.34

0.99

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3023

23171

1.04

0.98

1.2

2.15

1.70

u/ml

0.77

738

6062

(3023419) Bacteria identified in Sputum by Culture

278

1975

1.11

0.98

2.4

2.5

—

(3006462) Nitrate [Presence] in Urine

595

1.21

0.97

3.8

3.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

727

6109

0.94

0.97

3.0

4.24

4.41

pmol/l

4.61

636

5327

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

459

3343

1.09

0.96

2.3

1.5

0.00

g/l

-0.00

414

3041

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.51

0.95

1.2

1.7

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

114

0.55

0.94

1.0

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

176

0.63

0.94

1.3

1.6

—

(3010937) Rubella virus Ab [Presence] in Serum

2.26

0.94

1.0

—

(3025130) Human papilloma virus identified in Specimen

840

0.84

0.93

1.5

1.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

554

0.80

0.92

1.1

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.49

0.90

1.4

1.5

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.77

0.90

1.6

1.3

—

(3045424) Erythrocytes [Presence] in Urine

276

1971

1.11

0.90

1.8

1.5

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

103

0.54

0.89

1.0

—

3.50

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

248

0.70

0.89

1.9

1.8

1.15

1.19

mmol/l

0.99

239

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

104

0.53

0.88

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

229

0.69

0.88

1.4

1.7

143.54

59.28

au/ml

—

(3010838) Calcium [Moles/time] in 24 hour Urine

240

2101

0.90

0.87

1.7

1.8

4.48

4.93

mmol/24h

1.10

208

1813

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

100

669

1.18

0.86

1.9

1.7

—

(3046861) Legionella sp Ag [Presence] in Urine

1.69

0.86

1.2

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

469

0.79

0.85

2.3

2.9

30.13

28.62

umol/l

0.40

352

(3009214) Lutropin [Units/volume] in Serum or Plasma

255

1822

1.11

0.84

1.3

15.63

9.16

u/l

6.74

196

1445

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

498

1.21

0.83

1.6

1.8

141.63

114.65

umol/l

0.20

253

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

168

1173

1.13

0.83

1.3

1.2

—

35.89

—

(3016750) Collection duration of Urine

119

812

1.16

0.82

2.1

493.85

500.68

min

0.26

610

(3004775) Volume in Urine collected for unspecified duration

167

1168

1.13

0.81

2.0

2.3

720.66

665.27

0.68

794

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

286

1.27

0.81

1.0

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

535

0.81

1.2

146.18

163.35

mmol/24h

0.70

535

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.56

0.80

1.6

1.4

22.80

22.88

mmol/l

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.80

0.0

5.7

—

0.34

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.50

0.78

1.2

1.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5856

45471

1.02

0.78

4.5

4.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

378

2765

1.08

0.77

1.1

5.15

9.46

u/ml

1.28

251

(3013247) Albumin in CSF/Albumin in Serum or Plasma

138

0.63

0.76

1.3

1.1

12.87

8.16

mg/g

0.45

129

(3024869) Neuronal Ab [Presence] in Serum

212

1.30

0.76

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

268

1.27

0.75

1.0

1.1

81.71

86.22

0.30

135

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

254

1830

1.10

0.74

1.1

3971.67

6932.81

iu/ml

0.16

351

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

290

1.25

0.74

2.7

2.5

7.80

8.02

mmol/l

0.13

179

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

213

1.30

0.74

1.0

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.61

0.73

4.1

3.4

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1.61

0.73

8.2

6.7

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.78

0.72

1.4

1.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

901

7442

0.95

0.72

2.0

2.2

11.44

14.72

nmol/l

23.73

777

6612

(40757494) Bilirubin.total [Moles/volume] in Blood

106

727

1.15

0.71

2.3

2.0

99.18

16.54

umol/l

1.49

(3023511) Choriogonadotropin [Units/volume] in Urine

396

0.80

0.71

1.5

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

281

0.76

0.70

1.4

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

115

1033

0.88

0.69

1.1

—

(3022621) pH of Urine by Test strip

1092

8284

1.04

0.67

3.1

—

(3045414) Leukocytes [Presence] in Urine

716

5379

1.05

0.67

2.1

1.9

—

(40761535) Cells panel - Urine sediment

1346

10998

0.96

0.66

3.4

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.45

0.65

1.2

1.1

11.50

11.26

u/l

0.02

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

330

0.79

0.65

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

330

0.79

0.65

1.3

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

277

0.77

0.65

1.9

1.7

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

329

0.79

0.64

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

329

0.79

0.64

1.3

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

237

1718

1.09

0.64

1.6

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.72

0.63

1.4

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.44

0.62

1.3

1.7

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

129

1.35

0.61

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

283

0.78

0.61

1.0

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.61

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.61

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.61

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.61

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.61

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.61

0.0

2.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.61

0.0

1.4

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.61

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.61

0.0

2.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

143

1.32

0.61

5.8

4.8

74.46

50.17

ug/min

0.88

110

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

123

1087

0.89

0.60

1.1

1.5

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

0.00

0.60

0.0

1.7

—

119.11

—

(3034614) HLA Ag [Interpretation]

0.00

0.60

0.0

1.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

680

5621

0.95

0.60

1.4

1.5

14.30

15.90

u/ml

0.09

137

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

6309

49170

1.02

0.59

4.6

3.8

2.95

2.00

ug/l

5.84

5429

44087

(3047352) Trisomy 18 risk [Likelihood] in Fetus

272

0.78

0.58

1.3

1.4

—

(36660697) Celiac disease serology panel - Serum

1033

8455

0.96

0.58

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

103

1.38

0.58

1.2

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

103

1.38

0.58

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

103

1.38

0.58

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

117

1034

0.89

0.58

1.1

—

(3005033) Fetal Nuchal fold Thickness US

271

0.79

0.57

1.3

1.4

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

332

0.81

0.57

1.2

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

259

1897

1.08

0.57

1.2

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

501

0.85

0.54

1.2

59.00

55.14

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

346

0.82

0.53

1.2

110.82

140.09

nmol/l

0.80

242

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

189

1.25

0.53

1.0

1.2

81.27

81.84

0.03

(3012494) Peanut IgE Ab [Units/volume] in Serum

215

0.77

0.52

1.0

0.76

1.00

u/ml

—

102

(3029075) Extractable nuclear Ab panel - Serum

311

0.81

0.52

1.0

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.60

0.52

1.2

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

232

0.78

0.52

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

183

1.25

0.51

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

101

712

1.12

0.50

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

100

705

1.12

0.50

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.40

0.50

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

191

1.24

0.49

1.1

1.2

83.60

72.87

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

184

1.24

0.49

1.1

5.35

3.31

pmol/l

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

132

0.72

0.48

1.0

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.49

0.47

1.2

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.49

0.47

4.0

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.34

0.46

1.1

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

297

0.82

0.46

1.0

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

136

1.28

0.46

2.1

2.3

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

115

1.30

0.46

1.1

1.0

91.58

83.10

ug/l

—

(3003577) Lead [Moles/volume] in Blood

0.59

0.46

1.0

1.2

—

0.17

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

159

1.24

0.43

1.1

1.3

9.06

251546.34

nmol/l

0.91

130

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

294

0.83

0.43

1.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

137

0.75

0.42

2.6

1.6

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.41

0.0

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.46

0.40

3.0

1.2

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.40

0.0

1.0

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.40

0.0

1.3

—

285.13

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

3730

29048

1.02

0.40

3.5

3.8

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

168

1.22

0.40

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

388

1.14

0.40

7.2

7.7

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

367

0.86

0.39

1.3

32.55

35.84

0.22

246

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

135

0.76

0.38

1.2

1.1

—

(3000285) Sodium [Moles/volume] in Blood

196

0.81

0.38

1.1

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

176

1.21

0.38

1.0

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

113

818

1.09

0.38

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

151

0.78

0.36

3.5

5.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.65

0.36

2.4

8.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

236

1967

0.95

0.35

1.3

39.94

34.13

iu/l

1.39

194

1692

(3026389) Candida sp identified in Specimen by Organism specific culture

218

1625

1.06

0.35

1.3

1.4

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

400

1.12

0.35

1.8

1.7

197.34

160.59

2.09

370

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

295

0.86

0.34

1.0

1.1

—

(40768443) Skin Pathology biopsy report

589

4798

0.97

0.32

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

217

1.16

0.32

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

409

0.89

0.31

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.73

0.31

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

608

1.09

0.31

1.4

1.3

0.31

0.23

nmol/l

0.45

456

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.32

0.31

1.1

1.3

1.43

1.30

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

130

1.21

0.30

1.8

1.7

48.60

45.85

umol/l

0.18

130

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

291

0.87

0.30

1.0

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.28

0.30

1.0

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

123

1.22

0.30

2.2

2.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

300

1.13

0.30

1.0

1.2

305.35

290.54

pmol/l

0.09

206

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

540

4392

0.97

0.29

1.5

1.6

276.67

292.85

titre

0.04

219

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

612

0.92

0.28

1.2

1.6

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

161

1.18

0.28

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.26

0.28

15.5

9.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

145

0.82

0.27

1.7

1.8

—

(3019174) dRVVT (LA screen)

0.75

0.27

1.0

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

179

1487

0.95

0.27

1.2

1.3

291.13

354.20

pmol/l

0.41

153

1259

(3012898) Urea [Moles/volume] in Urine

125

1.20

0.27

1.2

1.3

221.58

163.54

mmol/l

0.50

115

(3017509) Phencyclidine [Presence] in Urine

0.68

0.26

1.8

1.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.66

0.26

3.4

3.3

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

319

1.11

0.26

1.4

597.53

78.31

nmol/24h

0.93

319

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

274

1.12

0.26

1.2

1.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

111

1.21

0.26

2.5

1.5

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

344

0.89

0.25

1.4

1.2

0.31

g/l

0.07

282

(3020491) Glucose [Moles/volume] in Blood

108

907

0.94

0.24

1.9

2.0

7.92

7.06

mmol/l

1.61

616

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

321

1.11

0.24

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

108

0.80

0.23

1.2

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.77

0.22

1.3

1.2

19.79

24.69

nmol/l

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

159

1196

1.05

0.22

1.1

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.20

0.21

1.0

1.2

—

mmol/l

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

274

0.89

0.21

1.1

0.63

0.66

umol/24h

0.25

119

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.79

0.21

1.0

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

175

1442

0.96

0.21

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.23

0.21

3.5

2.8

—

(3020961) Endomysium IgA Ab [Titer] in Serum

577

4654

0.98

0.20

1.1

205.75

217.14

titre

0.06

108

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.80

0.20

1.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

0.80

0.20

1.0

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

141

1062

1.05

0.20

1.1

1.2

96.61

95.45

0.23

127

991

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

272

0.90

0.19

1.0

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

280

0.90

0.19

1.1

1.2

1.07

38.80

mg/l

0.99

216

(37021550) Renin [Units/volume] in Plasma --upright

250

1.11

0.19

1.0

1.3

166.36

50.73

mu/l

0.99

177

(3034988) Calcium [Moles/volume] in Capillary blood

255

0.90

0.19

1.8

1.16

1.18

mmol/l

0.60

247

(43055514) Macroprolactin [Presence] in Serum or Plasma

123

1.16

0.18

1.3

1.6

—

(4146454) Self-monitoring of blood glucose

222

1694

1.03

0.18

2.8

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

335

0.92

0.17

1.4

1.6

12.52

9.18

ug/l

2.01

335

(3035947) Staphylolysin Ab [Units/volume] in Serum

612

1.06

0.17

1.1

5.00

4.04

iu/ml

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.72

0.17

1.0

1.1

—

26.92

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.72

0.17

1.0

—

(3044927) Protein electrophoresis panel - Urine

194

1480

1.03

0.16

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

236

0.90

0.16

2.0

1.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

640

5140

0.98

0.16

1.0

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

145

0.87

0.16

10.4

8.6

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

178

0.89

0.16

1.1

1.4

—

53.85

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

190

1450

1.03

0.16

1.2

2.79

4.09

u/ml

2.22

659

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

125

1.14

0.15

1.0

1.2

—

(3034426) Prothrombin time (PT)

323

1.08

0.15

1.2

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

163

1.11

0.15

2.2

2.3

41.76

41.72

umol/l

0.00

137

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

163

1.11

0.15

1.2

1.1

—

(3015183) Erythrocyte sedimentation rate

377

1.07

0.14

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.79

0.14

1.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.79

0.14

1.0

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

170

1385

0.97

0.14

1.1

112.36

116.77

1.17

155

1241

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.83

0.14

1.1

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

151

0.89

0.13

1.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

734

0.96

0.13

1.9

2.0

15.58

15.85

nmol/l

0.13

674

(3038071) Oxygen [Partial pressure] in Mixed venous blood

340

1.07

0.13

7.5

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

387

0.94

0.13

1.5

1.4

14.59

16.35

pmol/l

1.40

320

(3051593) INR in Capillary blood by Coagulation assay

741

0.96

0.13

14.3

10.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1004

8012

0.99

0.13

1.2

1.3

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.82

0.13

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

188

1.09

0.12

1.1

—

(3020650) Glucose [Presence] in Urine

265

1.07

0.12

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

263

0.93

0.11

1.4

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

116

0.88

0.11

1.4

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

496

0.95

0.11

2.4

2.2

54.69

54.45

umol/l

0.02

410

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

121

1.11

0.10

1.2

1.1

1.37

1.71

umol/24h

1.77

121

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.07

0.09

1.0

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

586

1.04

0.09

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

316

0.95

0.08

1.4

1.2

106.00

114.12

1.13

280

(3030313) Adrenal Ab [Titer] in Serum

0.81

0.08

1.0

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.81

0.08

1.4

1.5

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.79

0.08

1.0

0.02

0.05

u/ml

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.79

0.08

1.0

—

(3036048) Francisella tularensis Ab [Titer] in Serum

235

0.94

0.08

1.0

1.2

—

328.00

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

541

4314

0.99

0.08

1.1

6.62

11.02

u/ml

0.24

(3003721) Smooth muscle Ab [Units/volume] in Serum

0.83

0.07

1.0

1.2

—

1.65

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

190

1474

1.02

0.07

1.2

3.71

3.30

u/ml

0.15

509

(4212803) Bone marrow aspirate examination

101

1.09

0.06

1.0

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.11

0.06

1.1

—

(3017704) Immunofixation for Urine

670

1.02

0.06

1.4

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

117

942

0.98

0.06

1.3

1.4

0.89

1.37

promille

3.27

717

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

176

0.94

0.05

1.0

1.2

—

(3011985) Renin [Units/volume] in Plasma

198

1584

0.99

0.05

1.4

1.3

82.51

61.36

mu/l

0.44

172

1408

(40768446) Kidney Pathology biopsy report

447

0.97

0.05

1.3

1.6

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

459

3594

1.01

0.05

1.3

1.5

18.86

15.79

iu/ml

0.13

(3021387) Prolactin [Units/volume] in Serum or Plasma

243

1896

1.01

0.05

2.1

1.8

300.90

290.53

mu/l

0.20

223

1738

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

579

1.02

0.04

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

451

3579

0.99

0.03

2.3

2.2

141.89

113.00

ug/min

0.55

250

2066

(3036180) Methadone [Presence] in Urine

252

0.97

0.02

1.4

2.3

—

(3035933) Granulocytes/100 leukocytes in Blood

167

1.04

0.02

1.2

1.3

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

222

1.03

0.02

1.8

1.3

153.83

198.24

titre

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

568

0.99

0.02

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

275

0.98

0.02

5.7

7.3

—

(3013707) Erythrocyte sedimentation rate by Westergren method

11338

89446

1.00

0.02

3.8

4.2

18.23

12.51

mm/h

169.89

10313

81987

(3051387) C reactive protein [Mass/volume] in Capillary blood

359

2842

1.00

0.01

3.6

3.5

35.99

26.38

mg/l

4.41

236

1853

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

133

1.01

0.00

1.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

102

1.01

0.00

1.1

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

124

1.02

0.00

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.00

0.00

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

172

1.01

0.00

1.0

1.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

335

2647

1.00

0.00

1.1

1.3

172.00

135.64

titre

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

379

1.00

0.00

3.9

6.0

65.26

70.50

0.51

319

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

123

971

1.00

0.00

2.3

—

(3036525) Urea [Moles/time] in 24 hour Urine

1.02

0.00

2.6

2.8

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

312

0.99

0.00

1.2

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.0

1.3

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3025504) Homovanillate [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.0

1.1

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.92

-0.00

1.2

1.0

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

-0.00

0.0

1.2

—

18.88

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

-0.00

0.0

1.2

—

1.55

—

(3015057) Respiratory syncytial virus Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.89

-0.00

1.3

1.5

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

5.8

—

14.60

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

-0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

-0.00

0.0

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.94

-0.00

1.8

1.3

517.75

327.90

umol/24h

—

(3011048) Pyruvate [Moles/volume] in Blood

0.99

-0.00

1.0

1.2

65.67

87.28

umol/l

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.92

-0.00

1.2

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.97

-0.00

1.3

1.2

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_DIGESTIVE_ORGANS – Malignant neoplasm of digestive organs

GWS hits: 16

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of digestive organs

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints